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ABSTRACT 
Damaging and often irreversible effects occurring in aquatic ecosystems have recently 
been linked to the presence of pharmaceuticals in water bodies.  Because this crisis has only 
recently been identified, existing reports on the consequences of this contamination are scarce.  
In EPA standard acute effluent toxicity tests, Ceriodaphnia dubia, Daphnia pulex, Pimephales 
promelas, Mysidopsis bahia, and Menidia beryllina were subjected to two of the most widely 
distributed pharmaceuticals in the U.S., ethinyl estradiol (EE2), a synthetic form of estrogen, and 
fluoxetine HCl (FLX), the active ingredient in Prozac®, for 96 hours to assess and evaluate toxic 
responses.   
After test termination, mortality curves were statistically analyzed to quantify 96 hour 
median effective concentrations (EC50s), no observable effect concentrations (NOECs), lowest 
observable effect concentrations (LOECs), and chronic values (Ch.V.s).  
Derived EC50s for both drugs identified C. dubia as the most sensitive organism.  In 
terms of the Ch.V., C. dubia was the most sensitive organism administered EE2 and M. bahia 
given FLX.   The most resilient species was P. promelas regarding the EC50 after EE2 dosing, 
D. pulex in respect to the Ch.V. after EE2 dosing, and M. beryllina pertaining to the EC50 and 
Ch.V after FLX dosing.   
Existing risk assessments and traditional toxicity tests do not incorporate sublethal 
effects. Because EE2 and FLX have the potential to alter serotonin, dopamine, and estrogenic 
hormones, biological activities encompassing these chemicals could be affected such as changes 
in behavior, growth and development, and fecundity.  Observations on exposed organisms 
indicate that there were sublethal effects. The observed increases in abnormal behaviors of 
exposed organisms included unresponsiveness, irregular swim patterns, erratic activity, and 
convulsions with observed decreases in feeding habits and aggression.   Ethinyl estradiol 
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appeared to accelerate maturation; elevated concentrations appeared to slightly stimulate 
maturity while appearing to inhibit molting.  The organisms exposed to higher concentrations of 
EE2 and FLX seemed to lack pigment. 
Continuous environmental pollution of these unregulated chemicals can cause stress on 
aquatic ecosystems and result in disturbances of the normal development and life cycles of 
aquatic organisms.   If these sublethal disruptions in biological activity continually disregarded, 
catastrophic destructions of entire ecosystems could transpire. 
 
 
1 
INTRODUCTION 
Pharmaceutical substances were designed with the intention of maintaining health and 
well being and are used as aids to diagnose, treat, or prevent disease. In order to perform their 
intended function, pharmaceuticals are designed with degradation resistance, accumulation 
potential, and toxicity potential in terms of effectiveness on biological key functions. However, 
through human activity, aquatic ecosystems have been exposed to these chemicals since their 
introduction into the market. Although drugs are not considered pollutants, they do fit the 
definition.  Pollutants may be classified by the following criteria:  origin (natural or synthetic), 
effects (on organs, species, or entire ecosystems), properties (mobility, persistence, and toxicity), 
and ease or difficulty of cleanup and/or removal.   
Comparatively little attention has been given to pharmaceuticals as potential 
environmental pollutants because they represent a fraction of man-made pollutants (pesticides 
and household and personal care products) present in the environment.  Additionally, because 
their existence has only been recently proven, it is still unclear how these chemicals affect 
ecosystems.  This does not belittle their potential to cause harm to the environment because 
pharmaceuticals are designed to be very efficient in producing a maximum response at a 
minimum dose.  The environmentally detected amounts of drugs have not been linked to 
significant declines in survivorship.  As a result, their potential effects on the environment have 
gone overlooked. The United States Geological Survey (USGS) has established a baseline for 
contaminants of concern (COCs) in which pollutants have the potential to affect the health and 
welfare of aquatic ecosystems and humans.  Pharmaceuticals with modes of action depending 
upon signal transduction, cell division, and key metabolizing enzymes can be hazardous to 
nontarget organisms that possess or lack the necessary elements to carry out the drugs function. 
The problem is that although pharmaceuticals were not designed to affect organisms, they have 
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been recently linked to damaging sublethal effects of nontarget organisms living downstream of 
wastewater treatment plants (WWTPs).  Definitive effects need to be identified in order to 
develop a solution before effects become out of control and irreversible.   
Pharmaceuticals as Pollutants  
Every year people use thousands of tons of drugs to treat illnesses, to prevent unwanted 
pregnancy, or to face the stresses of modern life.  The production and consumption of two of the 
most popular pharmaceuticals in the United States, ethinyl estradiol and fluoxetine, are 
increasing at an exponential rate.  However, environmental concern is not exclusively based on 
high production rates; the chemicals’ properties and behavior in the environment should also be 
considered.  Pharmaceuticals fit the definition of pollutants in which they are introduced in 
appreciable amounts, exhibit environmental persistence, and cause damaging effects on 
ecosystems (Ritter 2006).   
However, they are often discounted as pollutants and they are not regulated by 
environmental agencies.  Regulations control priority pollutants in wastewater treatment plants’ 
(WWTPs) effluent but because pharmaceuticals are not classified as priority pollutants they are 
not regulated. 
Although pharmaceuticals fit the definition of emerging pollutants, they are disregarded 
as COCs for a number of reasons.  First of all, the production and testing of drugs is under the 
Food and Drug Administration (FDA).    Drugs were seldom considered potential environmental 
pollutants because the international regulation of pharmaceuticals is regulated by human health 
agencies which do not focus on environmental concerns.  Thus once the chemical is excreted 
from the user, the fate of active pharmaceutical ingredients (APIs) has been disregarded 
(Daughton and Ternes 1999).  Personal use and excretion of drugs are a less visible source of 
these potential contaminants because they are unintentionally emitted into the environment.  
 
 
3 
Pharmaceuticals entering the environment via excretion are under not regulated or monitored by 
environmental laws.  Resource Conservation and Recovery Act (RCRA) does not regulate any 
household waste under the control of consumers, which includes medicational waste (USEPA 
2010).  Regulations control priority pollutants in WWT effluent but because pharmaceuticals are 
not classified as priority pollutants they are not regulated. 
Portions of active pharmaceutical ingredients (APIs) that are not fully absorbed by 
humans nor completely degraded by metabolic processes are secreted in urine or feces and then 
emitted into raw sewage (Halling-Sorensen et al. 1998; Daughton et al. 1999).  Primarily through 
untreated and treated sewage effluent these compounds have been continuously flowing into the 
aquatic environment for as long as people have been taking them.  Hence they are present 
anywhere that humans visit or live.  Because drugs are polar and nonvolatile, they are unable to 
escape from the aquatic zone. Aquatic organisms are exposed to pharmaceuticals through the 
aforementioned pathway for their entire life-cycle making them susceptible to the chemicals’ 
effects.   
Because they occur in small amounts, their existence has only recently been proven 
through advancement in analytical methods.  These highly water soluble compounds could not 
be analyzed using the normal sample clean-up/preconcentration methods, with gas 
chromatographic separation typically used for aquatic pollutants (Daughton et al. 1999).  It was 
not until the 1990s that analytical methods were substantially advanced with high separatory 
efficiencies to detect the low levels of pharmaceuticals in the environment (Daughton and Ternes 
1999).  With the amounts of pharmaceuticals produced and consumed exponentially increasing it 
is difficult to analyze every API.  Most pharmaceuticals and their metabolites are not presented 
in environmentally oriented mass spectral libraries.  Also, any available analytical reference 
standards are expensive and difficult to obtain (Daughton and Ternes 1999).  In order to 
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minimize environmental contamination, pollution prevention should be favored over remediation 
or restoration. 
Risk Assessment 
Because environmental toxicology focuses on acute effects of exposure, traditional 
toxicity tests simply survey mortality; in this way, these tests are oversimplified because they do 
not account for body burdens.  It should be noted that besides known targets additional or other 
target tissues and organs may be affected alternatively. This would result in unexpected effects 
not targeted by the typical regulations.  Because environmental concentrations are below those 
necessary to cause mortality, lethality alone is not a sufficient enough endpoint to determine 
potential effects on environment.   
Risk assessment is flawed because it does not incorporate body burdens; these chemicals 
cause changes not anticipated by human tests due to physiological differences of nontarget 
organisms.  Traditional toxicity tests usually designate mortality as a significant endpoint and in 
a few cases size or reproduction.   
More specific toxicity analysis should be developed implementing the available 
knowledge generated during the pharmaceutical development process (e.g. pharmacokinetic 
behavior and metabolism, probable and possible modes of action, target organs and tissues, and 
side effects in mammals).  It is important to take into account how the drug affects humans by 
means of which processes are disrupted, which organs and tissues are targeted to anticipate 
similar effects on nontarget organisms.  
Taking into account the vague understanding of specific and nonspecific modes of action, 
species differentiation, and nontarget organs and tissues affected, specific toxicity analysis is 
difficult to perform and complicated to anticipate. Given what is known about the drugs through 
experiment on humans, aquatic experimental outcomes should be targeted towards known target 
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modes of action based on the assumption of similar modes of action in different species and the 
various side effects in humans. In order to evaluate which drug produced which result the current 
study, like many other studies, was not performed in mixtures. 
Importance of Study 
 Because these chemicals are environmentally present in small amounts it is only recently 
that their existence has been proven.  Analytical techniques and instrumentation able to detect 
polar compounds at minute quantities have been particularly helpful to the advancement in 
knowledge of environmental occurrence of pharmaceuticals (Fent et al. 2006).  Minute amounts 
of chemicals, typically considered safe because they occur at trace amounts, can elicit 
unanticipated effects on ecosystems as evident by xenobiotics such as 
dichlorodiphenyltrichloroethane (DDT) and polychlorinated biphenyls (PCBs) which have 
hormone mimicking effects on the reproductive systems of organisms at nanograms per liter 
(Colbum and Clement 1992).  
It is important to identify and investigate potential environmental pollutants before 
corrective measures are impossible. Since it is unlikely that people will be convinced to quit 
taking pharmaceuticals what do needs to be executed?  The primary studies on this subject must 
start at the beginning. Hence the purpose of this study is to prove that there is a problem.  
Environmental issues are typically excused until rehabilitation is almost irremediable brought to 
light by some catastrophic event, usually mortality.  Published literature is minute when you take 
into consideration the large amount of APIs, metabolites, and other transformation products 
developed and pumped into the environment, sublethal/lethal effects that may have not occurred, 
the number of potential non-target organisms (Daughton et al. 1999).   
 The results from this study can help form databases in which other drugs with similar 
modes of action or similar species to show effects (lethal and sublethal) and aid in future studies 
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to show what to look for. Often the type or magnitude of effects at lower concentrations is 
predicted from the acute tests which incorporate larger doses.   
Application of Results 
Although they are exposed to low doses throughout their entire life, acute toxicity studies 
which incorporate the large amounts needed to stimulate mortality are important to identify the 
effects in worst case scenarios such as spills, wastewater treatment outflow, and if 
pharmaceutical concentration increases due to bioaccumulation and the increase in potency.  
Taking into account subtle or seemingly unimportant changes that could affect environment or 
humans in the future could bring about changes in regulations, toxicity test practices, and public 
awareness.   
Simple observations during acute tests can aid in the analysis of environmental risk and 
eventually aid in the development of new test regulations. It is probable that sublethal effects 
could transpire from low concentrations. Although some effects may not be statistically 
significant this does not lessen their importance. 
Experimental ecotoxicological data for pharmaceuticals is scarce.  Sanderson et al. 
(2004) published ecotoxicological data for 2848 active pharmaceutical ingredients using 
(Quantitative) Structure Activity Relationship ((Q)SAR).  Environmental exposure is at least five 
orders of magnitude less than LC50.    
Ecological Structure Activity Relationships (ECOSAR) is a computerized program that 
predicts the acute (short-term) toxicity and chronic (long-term or delayed) toxicity of chemicals 
to aquatic organisms such as fish, aquatic invertebrates, and aquatic plants. ECOSAR uses 
Structure Activity Relationships (SARs) to predict the aquatic toxicity of untested chemicals (i.e. 
pharmaceuticals) regarding structural similarities of chemicals for which aquatic toxicity data are 
available. The SARs in ECOSAR express correlations between a compound's physicochemical 
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properties and its aquatic toxicity within specific chemical classes.  While many studies utilize 
the program to predict the ecotoxicity of pharmaceuticals, it is important to note that the model 
was created using industrial chemicals and the applicability of the models to predict effects of 
pharmaceuticals should be carefully considered.   
Maden et al. (2009) assessed the confidence in ECOSAR’s predictions.  Several key 
factors were considered during the ranking process:  total number of classes into which 
ECOSAR assigned the compound, presence of additional/unusual functionalities that could drive 
or moderate the toxicity within a selected class, similarity to compounds in the ECOSAR 
training set, overall size, and log Kow.  The probability of the API falling within the relevant zone 
of the class was classified by a numerical scale of 1-3.  A confidence interval of 1 was given to 
compounds likely to fall within the domain of the model; there was confidence that the SAR 
prediction for the pharmaceutical was correct.  A confidence interval of 3 was given to 
compounds unlikely to fall within the domain of the model causing less confidence in the 
prediction for the compound. Also given the number 3 were compounds ECOSAR allocated into 
four, five, or six different classes lessening confidence in the correct assignment of class. 
Because ethinyl estradiol fell into two ECOSAR classes (phenols and propargyl alc-
hindered) and the molecule was different than those in the training set the assigned rank was 3 
for phenols in all groups and propargyl alc-hindered class was ranked 3 for fish 96 hour LC50 
and no predictions for daphnia 48 hour LC50 and algae 96 hour LC50.  ECOSAR predicted a 
higher potency in phenol class:  fish 96 hour LC50, daphnia 48 hour LC50 and algae 96 hour 
LC50 (Madden et al. 2009).  
Fluoxetine was classified as aliphatic amine and given a rank of 3 for fish 96 hour LC50, 
daphnia 48 hour LC50 and algae 96 hour LC50 signifying that it was unlikely that the API fell 
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within the domain of the model and there was little confidence in the prediction of the compound 
(Madden et al. 2009).  
Objectives 
The current single species study was designed to expose standard EPA organisms to six 
concentrations of ethinyl estradiol and fluoxetine for 96 hours.  Based on EPA’s 5th edition 
(2002) acute static renewal test (EPA-821-R-02-012) test organisms (3 species of freshwater 
organisms and 2 species of marine organisms) were exposed to six concentrations and a control 
with four replications for 96 hours.  A fifth replicate of concentrations void of organisms was 
used for daily monitoring of water parameters.  Median effective concentrations based on 
lethality (EC50s) were quantified and the toxic responses were compared and contrasted.  
Mortality was documented daily to assess time framed dose-responses for each test organism.  
The highest test concentrations were chosen into order to induce at least 50% lethality (EC50).  
Quantified 96 hour EC50s were established for five standard EPA test organisms determined 
after test termination.  
Because the environmental amounts are below those to stimulate mortality these results 
of this study extend beyond lethality through the observation of sublethal effects which are not 
required for acute test methods.  In addition to high toxicity potential these two pharmaceuticals 
are extremely potent in controlling hormonal, serotonergic, and dopaminergic systems in 
mammals/humans which could interfere with key biological functions including but not limited 
to fecundity, growth and development, and behavior in nontarget organisms.  Organisms are 
exposed for entire life cycles in environmental settings.  In the current study juvenile organisms 
were exposed during an important life stage of growth and development.  Any changes could be 
important to note because they were occurring within 96 hours.  
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Hypothesis   
1.  Higher concentrations are expected to initiate lethality in at least half of the test 
organisms. In the current study single species acute toxicity tests were conducted to document 
and quantify mortality and to assess behavior after exposure to ethinyl estradiol, a synthetic 
steroid present in most forms of birth control and fluoxetine, a selective serotonin reuptake 
inhibitor used to treat depression.  The higher concentrations are expected to initiate lethality in 
EPA standard test organisms, Ceriodaphnia dubia (water flea), Daphnia pulex (water flea), and 
Pimephales promelas (fathead minnow), which are freshwater species and Mysidopsis bahia 
(mysid shrimp) and Menidia beryllina (inland silverside) which are marine organisms.   
2.  Similarly classified organisms are expected to generate comparable mortality data. 
Mortality data is projected to be comparable to similarly classified organisms.  For example, 
water fleas and mysid should generate toxic responses similar to other crustaceans. 
3.  The lethal concentrations are expected to be smaller in simpler organisms and larger in 
more complex organisms.  The median lethal concentrations (EC50s) are expected to be smaller 
in these simpler organisms with shorter life cycles, making them more susceptible and vulnerable 
to contaminants.  Because fish are more complex organisms with more intricate bodily functions 
and longer life cycles they are expected to yield higher EC50s making them more resilient to 
these drugs.  The concentrations needed to induce mortality in these fish species should be 
comparable to other fish species and higher than the amounts in crustaceans.  
4.  The lesser concentrations are likely to generate less lethality while diminishing 
activity.  It is probable that sublethal effects could transpire from lower concentrations.  
Therefore, in addition to quantifying mortality, observations of behavioral changes were 
recorded.  It was expected that the lesser concentrations used in the present study were likely to 
generate less lethality while diminishing normal activity. 
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Perspective of Planned Research  
By proving the question that pharmaceuticals can affect organisms over short periods of 
time, it can be argued that the problem will only increase because aquatic organisms are 
environmentally susceptible to these chemicals throughout entire life cycles with multiple doses.  
Bioconcentration and the addition of new pharmaceutical products on the market may 
lead to higher concentrations of the compounds studied in the environment.  The pharmaceutical 
companies are producing more effective products for humans in order to perform their intended 
action pharmaceutical companies by increasing potency, bioavailability, and degradation 
resistance.  This means more negative impacts for environment.  Also because now our culture is 
saying a pill can cure anything, the amounts used are increasing along with the human population 
and availability of these drugs.    Also mixture effects are most often anticipated by the idea of 
concentration addition in which the combined toxicity is derived from the addition of the 
individual concentrations of each compound.  With this said, in the current study, species 
exhibited similar sublethal endpoints in both drugs. With this in mind, hypothetically 
concentrations that do not illicit lethality can cause sublethal effects and based on additions can 
occur at environmentally detected levels.  
The environmental concentrations of EE2 and FLX could potentially increase due to the 
exponential increase of the amounts being taken.  Also these drugs are prescribed for long time 
use with a large amount of the API excreted and entering the environment.   The long half lives, 
high resistance to degradation, high accumulation potential, and high water solubility allow these 
chemicals to persist in the environment.  Moreover, the pharmaceutical industry is producing 
more effective active APIs by increasing potency, bioavailability, and degradation resistance.  
These oppositions increase the potential for these compounds to remain in animal tissue and 
bioaccumulate enforcing biomagnifications and bioconcentrations.   
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This study covers a spectrum of aquatic organisms (simple and complex) and their food 
source to help demonstrate what can happen if an organism is affected and thus the food chain 
which may intern affect humans.  There is the cases in which physiological differentiation can 
play a role (i.e. aquatic organisms will react differently than mammals).   More complex 
organisms that are distressed at higher concentrations can be affected at lower levels of 
contamination in the sense that their food source is simpler and will be stressed at lower 
concentrations.  The current study included quantified effects of simple and complex organisms 
to aid in investigating aquatic ecosystems as a whole.  Changes at any level of the food chains 
will upset environmental balance.  Previously documented tests do not incorporate effects of 
food sources nor do they take into account how these changes affect the test organism.  The 
existence of these studies demonstrates that a problem can occur but by the time the public 
realizes it may be too late.   
In addition to quantified EC50s, concentration boundaries were noted for sublethal 
effects observed during the test.  The organisms were exposed to high concentrations during 
sensitive life stages which could aid in understanding how they affect nontarget organisms, 
anticipating effects for future studies, and/or risk assessment at environmentally detected 
concentrations.   
It is the unpredicted effects that are causing harm to ecosystems. Abnormalities have a 
number of possible explanations or in some cases, cannot be explained.  A major concern is the 
effects which are barely noticeable but accumulate over time to yield extreme changes masked 
by time and perhaps not distinguishable from natural events. Even subtle alterations in normal 
life progressions control the promise to directly or indirectly affect entire species populations.  
Any degree of disturbance of the environmental balance can bring about catastrophes leading to 
deteriorations of entire ecosystems.  
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LITERATURE REVIEW 
Pharmaceutical Industry 
Pharmaceutical chemicals are defined as prescribed and nonprescribed ―intended to affect 
the structure or any function of the body of man or other animals.‖ These substances are 
responsible for physiological or pharmacological action used to prevent, diagnose, cure, treat, or 
mitigate diseases (The Food, Drug and Cosmetic (FD&C) Act, sec. 201(g) (1)).  Pharmaceuticals 
can serve as preventatives to disease and disability (e.g. lipid-lowering drugs that lessen the risk 
of coronary artery disease) and aid in the management of the body’s self-regulating systems (e.g. 
high blood pressure and thyroid drugs) in which they can replace or supplement needed 
chemicals (e.g. insulin and vitamins).  They can cure some diseases (e.g. antibiotics), serve as 
new treatments where previously there were none (e.g. drugs for HIV), control symptoms (e.g. 
analgesics or pain relievers and asthma drugs), or can serve as complements to medical 
procedures (e.g. anticoagulants during heart valve replacement surgery) (Berndt 2001; Chockley 
2001).  
There are numerous groups of pharmaceuticals including but not limited to human and 
veterinary medicinal compounds; nutraceuticals, which are bioactive food supplements; and the 
classic small molecule drugs which are manufactured primarily through organic synthesis and 
biotech drugs.  At the end of 2009, the Food and Drug Administration had approved more than 
1,350 small molecule drugs, 123 biotech drugs (protein/peptide), 71 nutraceuticals and more than 
3,243 experimental drugs (Hazardous Substances Databank 2009). Every year thousands of tons 
of drugs are utilized to treat illnesses, to prevent unwanted pregnancy, or to face the stresses of 
modern life (National Center for Health Statistics 2004). 
The per capita consumption of pharmaceutical drugs is steadily increasing because of 
expiration of patents resulting in availability of less expensive generics and the discovery of new 
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uses for existing drugs.  Between 1988 and 1994, 39% of Americans were using at least one 
prescription drug and 12% of Americans were using at least three prescription drugs.  In 2005, 
the percentage of Americans using one prescription increased to 44%, and 17% were using at 
least three prescription drugs (National Center for Health Statistics 2004). 
North America represents about half of global pharmaceutical sales. Pharmaceutical sales 
in the United States increased from $152.8 billion in 2000 to $248 billion in 2004.  This 
dominant market is expected to reach $330 billion by the year 2010 with an estimated annual 
growth rate of 8.5%.  The exponential increase in pharmaceutical consumption is correlated with 
increasing population, advancing medical technology and research, increasing life span 
expectancy, and escalating health care spending (Khetan and Collins 2007).  
Pharmaceutical sales in North America have been rising nearly seven times faster than 
the expanding population growth rate (Khetan and Collins 2007) which has risen an average 
annual growth rate of 1.2% (National Center for Health Statistics 2006). In 2006, the U.S. 
population was 300 million compared to 151 million in 1950 (National Center for Health 
Statistics 2004). 
An inverted age structure in the general population and a rise of new target age groups 
are major contributors to this market increase (Daughton 2003; Khetan and Collins 2007).  
Because of chronic disorders, older people are more likely to take more pharmaceuticals than 
younger individuals and have typically been targeted by marketing companies (Beers 2003). 
However, marketing strategies now encompass all age groups by emphasizing the idea that a pill 
can cure anything and increase life expectancy.  However, patents are expiring allowing generics 
to become available at a lower cost making them more available to the public (Khetan and 
Collins 2007).  
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Two of the most popular pharmaceuticals in the United States have been available for 
decades.  The Federal Drug Administration approved the use of the synthetic estrogen ethinyl 
estradiol in June 1943 for birth control or hormone treatment, and the Selective Serotonin 
Reuptake Inhibitor, fluoxetine in December 1987 as an antidepressant (Food and Drug 
Administration).  Ethinyl estradiol ranked 8
th
 and fluoxetine ranked 13
th
 based on the number of 
prescriptions dispensed in 2004 in the United States (The Internet Drug Index 2010).  
Ethinyl Estradiol Mechanics 
The most frequent uses of ethinyl estradiol, a synthetic form of estrogen, are as combination 
oral contraceptive or hormone replacement therapy in postmenopausal women (Hardman 1996).  
It is applicable in the treatment of:  
 menopausal and post menopausal symptoms  
 moderate to severe vasomotor symptoms (International Agency for Research on Cancer 
1999; United States Pharmacopeia Drug Information 1999) 
 malignant neoplasm of the breast and prostate (International Agency for Research on 
Cancer 1999) 
 metastatic breast carcinoma in selected men and postmenopausal or oophorectomized 
women  
 female hypogonadism, primary ovarian failure, or ovariectomy  
 advanced prostatic carcinoma (United States Pharmacopeia Drug Information 1999) 
 Turner's syndrome  
 acne in women  
 athletic functioning as an enrichment supplement and veterinary supplements (Daughton 
and Ternes 1999)  
 
Ethinyl estradiol is prepared from natural estrogen (United States Pharmacopeia Drug 
Information (USPDI) 1999).  Desirable therapeutic actions on the female reproductive tract 
involve stimulation of proliferation and differentiation in the fallopian tube, an increase of the 
tubal muscular activity, an increase of the water content of cervical mucus, and support in 
contraction of the uterine myometrium. Estrogens increase the synthesis of DNA, RNA, and 
various proteins in target tissues. Estrogens reduce the release of gonadotropin-releasing 
hormone from the hypothalamus, leading to a reduction in release of follicle-stimulating 
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hormone and luteinizing hormone from the pituitary while the pituitary mass is increased 
(USPDI 1999).   
Ethinyl estradiol is rapidly and completely absorbed from the gastrointestinal tract (USPDI 
1999).  This lipophilic synthetic steroid diffuses readily through cellular membranes to bind to 
estrogen receptors in the nucleus in order to regulate gene expression by increasing or decreasing 
the transcription of hormone regulated genes depending on the tissue receptor which is activated.   
Ethinyl estradiol activates the estrogenic receptor and regulates gene expression in the female 
reproductive tract, pituitary, hypothalamus, bone, liver, and other tissues (Hazardous Substances 
Databank).Receptor activation differs upon which targets are affected (USPDI 1999).  The 
reported bioavailability of circulating EE2 is 40% almost fully bound to plasma albumin.  Oral 
ingestion results in peak plasma concentrations 2-3 hours later with a 12 hour peak thought to 
represent extensive enterohepatic circulation (USPDI 1999).  Unbound molecules are widely 
distributed to most tissues, especially breast, uterine, vaginal, hypothalamic, and pituitary tissues; 
with a high affinity for adipose tissue (USPDI 1999).  Metabolism involves hydroxylation of the 
aromatic ring in the liver by the cytochrome P450 3A4 isoenzyme after it is absorbed by the 
small intestine.  Metabolism is slow compared to estrogen.  The ethinyl substitution (C-triple 
bond-CH group) in the C17 position inhibits first-pass metabolism (USPDI 1999).  Primary route 
of biotransformation is through 2-hydroxylation and the formation of 2- and 3-methyl ethers 
(USPDI 1999).   
Following a single oral therapeutic dose biological half life is approximately 7.7 hours 
(USPDI 1999).  The elimination phase half-life has been reported to be 13 to 27 hours (Hardman 
et al. 1996).  In contrast to the metabolites of natural estrogen, a significant proportion of the 
metabolites of ethinyl estradiol in humans are excreted by the fecal route; ethinyl estradiol itself 
is excreted in urine and feces in a ratio of about 4:6.  About 90% of the metabolites from ethinyl 
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estradiol are recovered in both feces and urine (International Agency for Research on Cancer 
1999). Excretion is via feces due to some enterohepatic circulation of sulfate and glucuronide 
metabolites; excretion is also via the kidneys (Hazardous Substances Databank 2009). Excretion 
is mainly through urine; however, the enterohepatic circulation of the sulfate and glucuronide 
metabolites allows it to also be excreted in feces (Hazardous Substances Databank 2009). The 
metabolites glucuronide and sulfate conjugate as well as the unabsorbed portion are excreted as 
both urine and feces.   
Fluoxetine Mechanics 
 Fluoxetine is classified as an antidepressant for the treatment of major depressive 
disorder and to relieve the symptoms of premenstrual dysphoric disorder (PMDD).  Acute 
depressive episodes typically require 6-12 months of antidepressant therapy while chronic 
depression may require long-term treatment. Fluoxetine is also used in the treatment of:   
 obsessions and compulsions in patients with obsessive-compulsive disorder  
 binge-eating and vomiting behaviors in patients with moderate to severe bulimia nervosa 
(United States Pharmacopeia Drug Information (USPDI) 2003; O'Neil 2001)  
 short term management of exogenous obesity for a limited number of patients (McEvoy 
2003) 
 
The precise mechanism of antidepressant action of fluoxetine is unclear, but the drug has 
been shown to selectively inhibit the reuptake of serotonin (5-HT) at the presynaptic neuronal 
membrane (McEvoy 2003). Fluoxetine, like most Selective Serotonin Reuptake Inhibitors, 
hinders the 5-hydroxytryptamine transporter (5-HTT), a serotonin transporter in the central 
nervous system (Kreke and Dietrich 2008).  Thus this inhibition increases the concentration of 
serotonin and reinforces serotonergic neuronal transmission.  Fluoxetine specifically inhibits 
central nervous system (CNS) neuronal re-uptake of serotonin, thus increasing the concentration 
of the serotonin at the synapse and reinforcing of serotonergic neuronal transmission.  Fluoxetine 
has little effect on other neurotransmitters and may interact with other drugs or circumstances 
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which cause serotonin release (International Programme on Chemical Safety (IPCH) 1999). 
Fluoxetine-induced inhibition of serotonin reuptake causes increased synaptic concentrations of 
serotonin in the CNS, resulting in numerous functional changes associated with enhanced 
serotonergic neurotransmission (McEvoy 2003). The enhancement of the serotonergic effects 
may produce a life-threatening serotonin syndrome (USPDI 2003).   
 Most SSRIs only increase the amount of serotonin.  Fluoxetine increased extracellular 
concentrations of serotonin, norepinephrine and dopamine after acute dosing.  The concentration 
of monoamines was sufficient in blocking 5-HT receptors accounting for the increase of 
catecholamines (Bymaster et al. 2002).   
Fluoxetine hydrochloride administered orally is readily absorbed from the gastrointestinal 
tract with peak plasma concentrations appearing from 6 to 8 hours later.  The systemic 
bioavailability is greater than 85% and does not appear to be affected by food with plasma 
protein binding at 94% (IPCH 1999). 
Fluoxetine is widely distributed throughout the body with highest concentrations 
occurring in the lungs and liver; however, distribution of fluoxetine and its metabolites into 
human body tissues and fluids has not been fully characterized (USPDI 2003).  It is known that 
fluoxetine and norfluoxetine cross the blood-brain barrier in humans and animals one hour after 
administration with concentrations present in the cerebral cortex, corpus striatum, hippocampus, 
hypothalamus, brain stem, and cerebellum (McEvoy 2003).  
When metabolized, fluoxetine undergoes N-demethylation catalyzed by the cytochrome 
P-450 isoenzyme CYP2D622 in the liver which produces the metabolite norfluoxetine which is 
just as active as the parent compound. Fluoxetine is metabolized to norfluoxetine, a desmethyl 
active metabolite similar to FLX, by the liver with peak plasma concentrations occurring 76 
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hours after dosing (USPDI 2003).   Under normal conditions, the concentration of the metabolite 
is greater than the parent compound (Hiemke and Härtter 2000). 
The long and highly variable half-life of FLX ranges from 1 to 4 days after a single dose 
with an average of nearly 70 hours.  However, after receiving high doses over long periods of 
time prolonged elimination half-lives may occur.  Norfluoxetine has a half-life of about 7 to 9 
days (IPCH 1999).  The primary hypothesized primary route of elimination is further hepatic 
metabolism to inactive metabolites which are conjugated and then excreted in the urine 
(Hemeryck and Belpaire 2002).  Less than 10% unchanged parent compound is primarily 
excreted in urine (Hiemke and Härtter 2000). 
Entrance into the Environment 
Active pharmaceutical ingredients (APIs) enter the environment through a variety of 
pathways.  The major pathway is through WWT facility effluent.  Unmetabolized portions or 
active metabolites that are not absorbed are secreted in urine or feces and then emitted into raw 
sewage (Halling-Sorensen et al. 1998; Daughton et al. 1999).  Flushing unused medications is a 
minor pathway which appears to be of lesser importance than the primary pathway of excretion 
(Heberer 2002).  Unused or expired pharmaceuticals are often flushed thus contributing to the 
environmental pollution (Halling-Sorensen et al. 1998). Drugs administered close to the end of 
one’s life can leach from cemeteries and into groundwater (Daughton 2003). Pharmaceuticals 
may enter the environment through drug-containing waste from manufacturing facilities 
(Daughton and Ternes 1999).   
After oral administration pharmaceuticals can either be fully or partially absorbed from the 
gastrointestinal tract and then degraded by metabolic processes. After the drug is metabolized by 
the body it is only slightly changed.  These by products are often times conjugated to polar 
molecules such as glucoronides.  Metabolism of the drug may occur to a large or small extent.   
 
 
19 
Excreted materials may include the metabolites, the parent molecule, or a mixture of both 
and are then released into the environment via wastewater effluent (Jones et al. 2001; Kummerer 
and Giampaolo 2006).  Most medical substances are metabolized to phase I or phase II 
metabolites before being excreted from the body with the urine and might arrive in the 
environment as such. Metabolic Phase I reactions usually consist of oxidation, reduction or 
hydrolysis, and the products are often more reactive, and sometimes more toxic, than the parent 
compound. Metabolic phase II reactions involve conjugation, which normally results in inactive 
water soluble compounds. Both phase I and phase II reactions change the physiochemical 
properties of the substance because biotransformation produces metabolites that are more water 
soluble than the parent compound. Thus, often it is not only the parent compound which should 
be the subject of risk assessment but also the primary metabolites.  
Parent compound  into more water soluble phase I metabolites 
Parent compound  into more water soluble phase II metabolites 
Phase I metabolite  into more water soluble phase II metabolite 
Phase II metabolites  into less water soluble parent compound or phase I metabolite 
(Halling-Sorensen et al. 1998). 
Wastewater treatment plants do not degrade all of the fractions of original pharmaceutical 
products.  Bacteria in the wastewater treatment process cleave these conjugate groups and the 
metabolites are restored to the parent compound (Heberer 2002; Halford 2008). These products 
enter the environment via treated or untreated raw sewage (Halling-Sorensen et al. 1998; 
Daughton et al. 1999; Ternes, 1998; Zuccato et al. 2000; Kummerer 2004; Halford 2008).  
Sewage systems are not equipped for removal of pharmaceuticals and personal care products 
(PPCPs). Currently, there are no wastewater treatment facilities that are engineered to remove 
pharmaceuticals or other unregulated contaminants such as personal care products. Effective 
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removal of these unregulated chemicals can differ depending on the properties of the chemical 
and on the individual sewage treatment facilities (USEPA 2010). The high polarity and low 
volatility of most pharmaceutical means that they are likely to be transported to the water 
compartment (Breton and Boxall 2003).  
Wastewater is often reused for drinking water which can increase the risk of 
pharmaceuticals reentering the human body as either the parent molecule or a transformed 
molecule (Khetan and Collins 2007).  Most drinking water treatment plants first add coagulant 
salts and polymers to destabilize colloidal particles.  Then the coagulated water is agitated to 
promote the aggregation of suspended materials.  Finally, water is stilled into order to settle 
suspended solids and floccules for removal.  This process, known as coagulation-flocculation-
sedimentation (C-F-S), is followed up by chlorination.  However, due to the polarity of most 
pharmaceuticals, they are not typically removed by the C-F-S process (Khetan and Collins 
2007).   
Leaching into groundwater can occur thus contaminating a potential drinking water 
supply. Pharmaceuticals are not significantly absorbed in the subsoil due to their polar structure 
(Khetan and Collins 2007).  Sewage treatment plants with longer solids retention times will 
remove more pharmaceuticals and other chemicals. The sorption coefficients (log Koc) to 
dissolved organic matter was 4.72 and for a model sediment of Elliott Silt Loam soil was 4.87 
(Yammomoto et al. 2005). Log Koc for FLX is 0.64, 0.97, and 3.70 at the pH 2, 7, and 11 
respectively (Brooks et al 2003a). 
Historical Background 
One of the first concerns of pharmaceuticals adversely affecting the environment was 
presented by a study investigating the biotransformation of estrogenic hormones by activated 
sludge which could impact the ecosystem (Stumm-Zollinger and Fair 1965; Tabak and Bunch 
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1970). In 1976 drugs were detected in sewage at the Big Blue River sewage treatment plant in 
Kansas City (Hignite and Azarnoff 1977).  The first reported occurrence of pharmaceuticals in 
USA treated wastewater was 8 x 10
-1
 – 2 ppb of clofibric acid (Garrison et al. 1976).  The most 
severe example of pharmaceutical contamination has been the feminizing of aquatic species to 
estrogenic compounds.  In the mid-1980s fish living in sewage treatment lagoons exhibited 
feminization (Daughton et al. 1999).  In the 1990s, scientists observed that male fish living 
downstream of WWTP began conceiving early-stage eggs in their testes and producing proteins 
associated with egg production typically occurring in female fish.  Feminized male fish have 
been reported in rivers and streams in the U.S. and Europe (Halford 2008). 
Behavior in the Aquatic Environment 
Pharmaceuticals and personal care products are continuously released into the 
environment. Ecosystems at maximum risks do not have upstream dilution (Brooks et al. 2003b).   
Active pharmaceutical ingredients (APIs) that may undergo environmental transformation by 
means of degradation or dilution can be offset by replacement discharges (Daughton et al. 1999). 
The behavior and fate of APIs and associated metabolites in the aquatic environment are 
not completely understood.  Low volatility denotes dispersal through aqueous transport with the 
possibility of food chain distribution (Fent et al. 2006).  The maximum solubilities in water have 
been established for EE2 (1 x 10
-2
 ppb) (Yalkowsky and Dannenfelser 1992) and for FLX (1 x 
10
-5
 ppb (mg/mL)) (O'Neil 2001).  
The operation of pharmaceuticals in surface waters is dependent on temperature and light 
intensity.  Low temperatures and shorter daylight hours typical of winter months may lead to 
decreased biodegradation and decreased photodegradation of chemicals.  Surface waters that are 
prone to snow and ice are less likely to break down pharmaceuticals.  In summer months, 
characterized by higher temperature and high levels of light, chemicals may become less potent 
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(Khetan and Collins 2007). Metabolites can be transformed to their parent molecule through 
waste water treatment (WWT) processes or environmental conversions.   
 The higher the log Kow (octanol-water coefficient) the more hydrophobic the compound 
is and the greater probability for bioaccumulation. Lipophilic xenobiotics (log Kow >3) are likely 
to enter fish bloodstreams primarily across the gills (Kreke and Dietrich 2008).The reported log 
Kow (octanol-water coefficient) for EE2 is 3.67 (Hansch et al. 1995) with a predicted log Kow of 
4.12 by ECOSAR (Sanderson et al. 2004).  The reported log Kow for FLX is 1.0, 1.8, and 2.6 at 
pH 5, 7, 9 respectively (Eli Lilly and Company 2005) and 1.25, 1.57, and 4.30 at pH 2, 7, and 11 
respectively (Brooks et al 2003a). The predicted log Kow by ECOSAR was 4.65 (Sanderson et al. 
2004).     
Bioaccumulation.  Upon entering the environment, the potential for bioaccumulation in 
food chains occurs (Kummerer and Giampaolo 2006).  The pharmaceutical industry is producing 
more effective active pharmaceutical ingredients (APIs) by increasing potency, bioavailability, 
and degradation resistance (Khetan and Collins 2007).  In order for pharmaceuticals to perform 
their intended action, they are resistant to biodegradation.  However this opposition to 
biodegradation increases the chances that these drugs bioconcentrate and biomagnify.  These 
drugs may remain in animal tissue and bioaccumulate enforcing biomagnifications (Carbonell et 
al. 2000).   
 Increase in accumulation of EE2 based on whole body residue of F1 generation 
Pimephales promelas (fathead minnow) embryos less than24 hours post fertilization (hpf) 
exposed to 5 x 10
-2
 ppb EE2 had a bioconcentration factor (BCF) of 660.  Those exposed to 2 x 
10
-4
 ppb had a BCF less than 2400.  The concentration 8 x 10
-4
 ppb yielded a BCF less than 500.  
Organisms exposed to 1 x 10
-2
 ppb had a BCF of 610 (Lange et al. 2001). An increase in 
elimination of EE2 was found in adult Oncorhynchus mykiss (rainbow trout) exposed for 0-50 
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days to 1 x 10
-3
 – 1 ppb based on residue in plasma of (Schultz et al. 2001). Juvenile Acipenser 
fulvescens (lake sturgeon) showed an increase in accumulation of residue in plasma at 6 x 10
-2
 
ppb with no effect at 1 x 10
-2
 ppb (Palace et al. 2001).  
Lepomis macrochirus (bluegill), Ictalurus punctatus (channel catfish), and Pomoxis 
nigromaculatus (black crappie) sampled from 100 meters downstream from the effluent 
discharge in Pecan Creek and L. macrochirus and Cyprinus carpio (carp) in Clear Creek had 
levels of fluoxetine in the brain.  These fish species studied from two streams in Denton County, 
Texas, USA represent a bioaccumulation effect.  However, the effects of 2 ppb FLX on the 
nervous system of fish have not yet been investigated (Brooks et al. 2005).   
Oryzias latipes (Japanese medaka) were exposed to fluoxetine at a nominal concentration 
of 6 x 10
-1 
ppb for 7 days and subsequently allowed to depurate in clean water over a 21 day 
period. Fluoxetine uptake by medaka was observed within the first 5 hours of exposure and the 
biologically active metabolite, norfluoxetine, was also detected in medaka tissues during this 
timeframe. Maximum FLX concentration was measured in medaka by the third day of the uptake 
phase, yielding an uptake rate constant (k1) of 5.9 ± 0.5 per day.  During the depuration phase of 
the experiment, a half life of 9.4 ± 1.1 days was determined for fluoxetine. Using these data, 
bioconcentration factor (BCF) values of 74 and 80 were estimated for fluoxetine and a pseudo-
BCF (the ratio of the concentration of norfluoxetine in medaka and the aqueous fluoxetine 
concentration) of 117 was calculated for norfluoxetine. These results indicate longer persistence 
and greater potential for the bioaccumulation of fluoxetine and norfluoxetine in fish tissues than 
would be predicted from prior half life estimates derived using mammalian species (Paterson and 
Metcalfe 2008).    
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Environmental Concentrations 
Persons prescribed these drugs take them for many months, usually years.  These 
medications are recommended for long term treatment which results in continuous pollution into 
environment.  Although pharmaceuticals have been present as long as humans have been taking 
them, it is through recent advancements in analytical instrumentation and techniques that their 
presence in the environment has been proven because they typically exist in nanograms per liter 
(Halford 2008).  Analytical techniques and instrumentation able to detect minute quantities of 
polar compounds have been particularly helpful to the advancement in knowledge of 
environmental occurrence of pharmaceuticals (Fent et al. 2006).   
Minute environmental concentrations of ethinyl estradiol have been detected in different 
media including but not limited to:  surface water (less than 2 x10
-4
 parts per billion (μg/L)), 
effluent from sedimentation tank (3-5 x10
-4
 ppb),  river water (2 - 15 x10
-3
 ppb), reservoir (1 - 3 
x10
-3
 ppb) and drinking water (less than 5 x10
-3
 ppb) (Halling-Sørensen et al. 1998).  The 
influent (3 x10
-3
 ppb) and effluent (4 x10
-4
 ppb) of a wastewater treatment facility reached 85% 
maximum removal by activated sludge (Baronti et al. 2000). 
Fluoxetine has been detected in the following media: municipal wastewaters (5 x10
-2
 
ppb) (Gange et al. 2006), reclaimed water facility effluent (5 x 10
-3
 ppb) (Kinney et al. 2006), 
waste water treatment plant effluent in Calgary, CA (5 x 10
-2
 ppb) (Chen et al. 2006), and stream 
waters (1 x 10
-1
 ppb) (Metcalfe et al. 2003b).  Weston et al. (2001) detected 5 x 10
-2
 ppb of FLX 
in WWT effluent with 79-82% recovery; however, with 67-77% recoveries for norfluoxetine, the 
metabolite was not detected.  Using isotope dilution liquid chromatography/tandem mass 
spectrometry the amounts of fluoxetine and norfluoxetine were analyzed from a number sewage 
treatment plant (STP) influents, effluents, and drinking water reservoirs.  The detected amounts 
of FLX were 2 x 10
-2
 ppb in the influent, 3 x 10
-2
 ppb in the effluent, 3 x10
-3
 ppb in the drinking 
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water.  Norfluoxetine was detected in the influent at 1 x 10
-2
 ppb, in the effluent at 4 x 10
-3 
ppb, 
and in the drinking water at 1 x10
-3
 ppb (Vanderford and Snyder 2006).   
In 2002 the United States Geological Survey (USGS) performed a national survey in 
which pharmaceuticals and personal care products (PPCPs) were detected in 139 rivers in 30 
states.  A plethora of biologically active compounds were detected in 80% of these populated and 
remote locations with an average recovery of about 60%.  Antibiotics and hormones were found 
with the greatest frequency in North American waterways.  Other detected pharmaceuticals 
included contraceptives, painkillers, anticancer drugs, blood-pressure medications, 
antidepressants, and drugs used to treat epilepsy. Ethinyl estradiol occurred with a frequency of 
16% with an estimated maximum of 8 x 10
-1
 ppb and an estimated median detectable 
concentration of 7 x 10
-2
 ppb.  Fluoxetine occurred with a frequency of 1% with an estimated 
maximum and median detectable level of 1 x10
-2
 ppb.  When compared to other man-made 
pollutants, pharmaceuticals represent a minute portion of environmental pollutants (Halford 
2008).   
Although the concentrations of some of these drugs may be considered small, these drugs 
were designed to have a profound effect at low concentrations (Koplin et al. 2002).  It is 
estimated that pharmaceuticals are environmentally present at concentrations below those needed 
to cause considerable harm.  It would rash to assume that these compounds were not affecting 
the ecosystems until there is irrefutable evidence to suggest otherwise (Jones et al. 2004).  
Studies have shown that concentrations of EE2 and FLX, many above the environmental 
detected levels, can stimulate health effects and lethality in animals and some plants (Jones et al. 
2004). 
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Lethal Effects of Ethinyl Estradiol 
Ethinyl estradiol produced LC50s for numerous organisms (Table 1).  Gammarus pulex 
(scud), when exposed to EE2, had a 72 hour LC50 between 2 x 10
3
 ppb - 4 x 10
3
 ppb.  The 
mortality increased from day 5-9 but the LC50 remained 0 - 2 x 10
3
 ppb.  The 10 day LC50 was 
8 x 10
2
 ppb (Watts et al. 2001).  The Tisbe battagliai (harpacticoid copepod) had a 10 day and 21 
day LC50 greater than or equal to 1 x 10
2
 ppb based on mortality (Hutchinson et al. 1999). 
Pounds et al. (2002) found the same LC50s based on survivorship.  
Table 1.  Exposure times and concentrations of ethinyl estradiol reported to provoke 50% 
lethality (LC50S) in aquatic organisms. 
Exposure 
Time 
Organism Dose 
(ppb) 
Trend/Response Reference 
24 hours 
Gammarus pulex  
(Scud) 
8 x 10
3
 Increase in Mortality Watts et al. 2001 
48 hours 
Acartia tonsa 
 (Calanoid Copepod) 
1 x 10
3
 Increase in Mortality Andersen et al. 2001 
48 hours 
Gammarus pulex  
(Scud) 
4 x 10
3
 Increase in Mortality Watts et al. 2001 
72 hours 
Gammarus pulex 
 (Scud) 
> 2 x 10
3
 
< 4 x 10
3
 
Increase in Mortality Watts et al. 2001 
96 hours 
Gammarus pulex  
(Scud) 
2 x 10
3
 Increase in Mortality Watts et al. 2001 
96 hours 
Neomysis integer 
(Opossum Shrimp) 
1 x 10
3
 Increase in Mortality Verslycke et al. 2004 
96 hours 
Nitocra spinipes 
(Harpacticoid Copepod) 
5 x 10
2
 Increase in Mortality 
Breitholtz and 
Bengtsson 2001 
96 hours 
Danio rerio  
(Zebrafish) 
2 x 10
3
 Mortality Versonnen et al. 2003 
5-9 days 
Gammarus pulex 
 (Scud) 
> 0 
< 2 x 10
3
 
Increase in Mortality Watts et al. 2001 
10 days 
Gammarus pulex 
 (Scud) 
8 x 10
2
 Increase in Mortality Watts et al. 2001 
10 days 
21 days 
Tisbe battagliai 
(Harpacticoid Copepod) 
≥ 1 x 102 Increase in Mortality Hutchinson et al.1999 
10 days 
21 days 
Tisbe battagliai 
(Harpacticoid Copepod) 
≥ 1 x 102 Decrease in Survival Pounds et al. 2002 
 
Generally exposure to ethinyl estradiol caused a decrease in hatchability (Table 2). 
Hatchability for Danio rerio (zebrafish) embryos 4-6 hours old with hatch times documented on 
days 1, 26, and 30 resulted in a 74 hour ET50 of 1 x 10
-3 
 ppb and 3 x 10
-3
ppb, and a 75 hour 
ET50 of 8 x 10
-3
 ppb (Bogers et al. 2006).  The decrease in hatchability of Pimephales promelas 
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(fathead minnow) exposed for 1 day post hatch caused an NOEC greater than or equal to 5 x 10
-2
 
ppb and an LOEC greater than 5 x 10
-2
 ppb (Lange et al. 2001). 
Table 2.  Exposure times and concentrations of ethinyl estradiol reported to provoke the 
endpoints associated with hatchability of aquatic organisms.  
Organism Response Exposu
re Time 
End 
Point 
Dose 
(ppb) 
Trend Reference 
Danio rerio 
(Zebrafish) 
Hatchability 
74 hours ET50 
1 x 10
-3
 
3 x 10
-3
  
Bogers et al. 
2006 
75 hours ET50 8 x 10
-3
 
Danio rerio 
(Zebrafish) 
Hatchability 58 days 
NOEC 1 x 10
-3
 
 
Hill and Janz 
2003 LOEC 1 x 10
-2
 
Pimephales promelas 
(Fathead Minnow) 
Hatchability 
1 dph 
 
NOEC ≥  5 x 10-2 Decrease Lange et al. 
2001 LOEC >  5 x 10
-2
  
 
Generally exposure to ethinyl estradiol caused a decrease in survivorship (Table 3).  A 
study supplying F0 generation Cyprinodon variegates (sheepshead minnow) with 2 x 10
-4
, 2 x 
10
-3
, and 2 x 10
-2
 ppb resulted in no toxicopathic stress; endurance was similar to controls.   
Survival was significantly reduced in subadults after 73 days in 4 x 10
-1
, 8 x 10
-1
, 2, and 3 ppb 
producing: an NOEC of 1 x 10
-1
 ppb and an LOEC of 3 x 10
-1 
ppb, and an MATC of 2 x 10
-1
 
ppb. F1 generation embryos retained a decrease in survivorship after 73 days, ensuing an NOEC 
of 9 x 10
-2 – 1 x 10-1 ppb, an LOEC of 3 x 10-1 – 4 x 10-1 ppb, and an MATC of 3 x 10-1 ppb 
(Zillioux et al. 2001).   Tisbe battagliai (harpacticoid copepod) less than24 hours old exhibited 
decreased survivorship launching 10 and 21 day NOECs greater than or equal to 1 x 10
2
 ppb and 
LOECs greater than 1 x 10
2
 ppb (Pounds et al. 2002). Hutchinson et al. (1999) found the same 
endpoints with a decrease in survivorship for the NOEC but found an increase in survivorship for 
the LOEC.  Based on decreased survivorship in Danio rerio (zebrafish) embryos after hatching 
the 1 day NOEC was 8 x 10
-3
 ppb.  An increase in survivorship was noted on days 26 and 30 
yielding an NOEC of 8 x 10
-3
 ppb (Bogers et al. 2006). Pimephales promelas (fathead minnow) 
embryos less than 24 hpf exposed for 28 days post hatch manifested diminished survivorship 
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yielding an NOEC of 1 x 10
-2
 ppb and an LOEC of 5 x 10
-2
 ppb.  Dosing for 56 days post hatch 
provoked an NOEC of 1 x 10
-2
 ppb with 22.99 – 23% mortality and an LOEC of 5 x 10-2 ppb 
with 25-31% mortality.  At 176-301 days post hatch an NOEC for survivorship was greater than 
or equal to 8 x 10
-4
 ppb with an LOEC greater than 8 x 10
-4
 ppb (Lange et al. 2001).  
Table 3.  Exposure times and concentrations of ethinyl estradiol reported to provoke the 
endpoints associated with survivorship of aquatic organisms. 
Organism Response End 
Point 
Dose 
(ppb) 
Trend Exposure 
Time 
Reference 
Hyalella azteca 
(Scud) 
Survivorship LOEL 1 x 10
2
   
Vandenbergh 
2003 
Tisbe battagliai 
(Harpacticoid 
Copepod) 
Survivorship 
NOEC ≥ 1 x 102 Decrease 10 and 21 days Hutchinson et 
al. 1999 LOEC > 1 x 10
2
 Increase  
Tisbe battagliai 
(Harpacticoid 
Copepod) 
Survivorship 
NOEC 
≥ 1 x 102 
 Decrease 
10 and 21 days Pounds et al. 
2002 
LOEC > 1 x 10
2
  
Cyprinodon 
variegates 
(Sheepshead 
Minnow) 
Survivorship 
NOEC 1 x 10
-1
 
Decrease 
73 days 
 Zillioux et al. 
2001 LOEC 3 x 10
-1
  
MATC 2 x 10
-1
  
Cyprinodon 
variegates 
(Sheepshead 
Minnow) 
Survivorship 
NOEC 
9 x10
-2
  – 
1 x 10
-1
 
Decrease 
73 days 
 
Zillioux et al. 
2001 LOEC 
3 x 10
-1
  – 
4 x 10
-1
 
 
MATC 3 x 10
-1
  
Danio rerio 
(Zebrafish) 
Survivorship NOEC 8 x 10
-3
 
Decrease 1 day Bogers et al. 
2006 Increase 26 and 30 days 
Oncorhynchus 
tshawytscha 
(Chinhook 
Salmon) 
Survivorship  4 x 10
2
 Decrease 194 dph 
Piferrer and 
Donaldson 1992 
Pimephales 
promelas  
(Fathead Minnow) 
Survivorship 
NOEC 
1 x 10
-2
 
 Decrease 
28 dph Lange et al. 
2001 
LOEC 5 x 10
-2
  
Pimephales 
promelas 
 (Fathead Minnow) 
Survivorship 
NOEC 1 x 10
-2
 
Decrease 
56 dph Lange et al. 
2001 LOEC 5 x 10
-2
  
Pimephales 
promelas  
(Fathead Minnow) 
Survivorship 
NOEC ≥ 8 x 10-4 
Decrease 
176-301 dph Lange et al. 
2001 LOEC > 8 x 10
-4
  
Tilapia aurea 
(Tilapia) 
Survivorship NOEL 2 x 10
5
  40 days Melard 1995 
 
Generally, exposure to EE2 increased mortality in aquatic organisms (Table 4).  Clutch 
Danio rerio (zebrafish) exhibited a decrease in hatchability resulting in a 58 day NOEC of 1 x 
 
 
29 
10
-1 
ppb and an LOEC of 1 x 10
-2
 ppb (Hill and Janz 2003).  Danio rerio (zebrafish) encountered 
mortality at 25 (46%), 30 (53%), 40 (53%), and 60 (53-54% mortality) days post hatch.  For all 
days post hatch, the reported NOEL was 2 x 10
-2
 ppb.  The LOEL for 20 days post hatch was 2 x 
10
-2
 ppb (Andersen et al. 2003).  Danio rerio (zebrafish) frys 2 dph had mortality after exposure 
for 58 days yielding an NOEC of 100 E-4 ppb and an LOEC of 1 x 10
-1
 ppb (Hill and Janz 
2003).  Pimephales promelas (fathead minnow) displayed an increase in mortality on days 0-
13.3 in 5 x 10
-2
 ppb; however, a decrease in mortality was observed on day 21 in 1 x 10
-2
 ppb 
(Lange et al. 2003). 
Table 4. Exposure times and concentrations of ethinyl estradiol reported to provoke the 
endpoints associated with mortality of aquatic organisms. 
Organism Response End 
Point 
Dose 
(ppb) 
Trend Exposure 
Time 
Reference 
Danio rerio 
(Zebrafish) 
Mortality 
NOEL 2 x 10
-2
 
 
10 dph 
Anderson et al. 
2003 
25 dph 
30 dph 
40 dph 
60 dph 
LOEL 2 x 10
-2
 20 dph 
Danio rerio 
(Zebrafish) 
Mortality  
5 x 10
-3 
– 
5x 10
-2
 
Increase 0-21 days 
Van den Belt et 
al. 2001 
Danio rerio 
(Zebrafish) 
Mortality  
3 x 10
-4
 
– 
9 x10
-2
 
Increase 21 days 
Islinger et al. 
2003 
Danio rerio 
(Zebrafish) 
Mortality NOEL 1  33 days 
Versonnen and 
Janssen 2004 
Danio rerio 
(Zebrafish) 
Mortality NOEL 1 x 10
-2
  58 days 
MacLatchy et 
al. 2003 
Danio rerio 
(Zebrafish) 
Mortality LOEL 5 (>50% died) 35 dph 
Ortiz-
Zarragoitia et 
al. 2006 
Danio rerio 
(Zebrafish) 
Mortality 
NOEC 5 x 10
-3
 
 
~ 16 days Nash et al. 
2004 LOEC 5 x 10
-2
  
Danio rerio 
(Zebrafish) 
Mortality NOEC 3 x 10
-2
 Decrease 40 days 
Andersen et al. 
2004 
Danio rerio 
(Zebrafish) 
Mortality 
NOEC 1 x 10
-2
 
 
58 days 
Hill and Janz 
2003 LOEC 
 
1 x 10
-1
  
Dicentrarchus 
labrax (Sea 
Bass) 
Mortality  1x 10
4
  
40 days 
200 days 
Blazquez et al. 
1998 
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(Table 4 continued) 
Organism Response End 
Point 
Dose 
(ppb) 
Trend Exposure 
Time 
Reference 
Etheostoma 
caeruleum 
(Rainbow 
Darter) 
Mortality 
 
1 Increase 
6-21 days 
 
 
Elias et al. 
2007 
Etheostoma 
caeruleum 
(Rainbow 
Darter) 
Mortality 
No 
Effect 
2  x 10
-1
  21 days 
Elias et al. 
2007 
Gambusia 
affinis  
(Western 
Mosquitofish) 
Mortality 
 
NOEL 1x 10
4
  150 days 
Angus et al. 
2005 
Oryzias latipes 
(Medaka) 
Mortality 
NOEL 
1 x 10
-4
 
μg/egg 
 
1 day 
 
 
 
Hano et al. 
2005 
LOEL 
5 x 10
-4
 
μg/egg 
 
Oryzias latipes 
(Medaka) 
Mortality  
1 x 10
-4
 
– 
1 
Increase 85-110 days 
Metcalfe et al. 
2001 
Pimephales 
promelas 
(Fathead 
Minnow) 
Mortality  5 x 10
-2
 Increase 0-13.3 days 
Lange et al. 
2003 
Pimephales 
promelas 
(Fathead 
Minnow) 
Mortality  1 x 10
-2
 Decrease 21 days 
Lange et al. 
2003 
Platichthys 
flesus  
(Starry, 
European 
Flounder) 
Mortality  
1 x 10
-3 
– 
1 x10
-2
 
Increase 21 days 
Allen et al. 
1999 
Pomatoschistus 
minutus 
 (Sand goby) 
Mortality  6 x 10
-3
 Increase 0 – 213.08 days 
Robinson et al. 
2003 
 
There are a few documented cases in which populations did not decline.  Danio rerio 
(zebrafish) that were 20 days old post hatch exposed for 40 days evoked a slight decline in 
mortality forming an NOEC of 3 x 10
-2
 ppb (Andersen et al. 2004).  Tilapia aurea (tilapia) 
yielded 94% survivorship forming a 40 day NOEL of 200000 ppb through dietary exposure 
(Melard 1995).  The following NOELS based on mortalities were recorded in Danio rerio 
(zebrafish): a 33 day exposure to 1 x 10
-1
 ppb (Versonnen and Janssen 2004), and a 58 day 
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exposure to 1 x 10
-2
 ppb (MacLatchy et al. 2003).  Sexually immature Gambusia affinis (western 
mosquitofish) fed EE2 through 150 days illustrated an NOEL of 1 x 10
4
 ppb (Angus et al. 2005).  
While an increase in fatality was observed in juvenile Etheostoma caeruleum (rainbow darter) in 
1 ppb exposed for 6-21 days, exposure after 21 days in 2 x 10
-1
 ppb caused no effect on mortality 
(Elias et al. 2007).  Pimephales promelas (fathead minnow) displayed an increase in mortality on 
days 0-13.3 in 5 x 10
-2
 ppb; however, a decrease in mortality was observed on day 21 in 1 x 10
-2
 
ppb (Lange et al. 2003).  An increase in survivorship was noted on days 26 and 30 yielding an 
NOEC of 8 x 10
-3
 ppb Danio rerio (zebrafish) (Bogers et al. 2006).  
Lethal Effects of Fluoxetine 
Lethal concentrations (LC50s) were documented for different aquatic organisms (Table 
5).  A 24 hour LC50 was reported for Thamnocephalus platyurus (fairy shrimp) 8 x 10
2
 ± 1 x  
10
2
 (Nalcz-Jawecki 2007).  Juvenile Cyprinodon variegatus (sheepshead minnow) 43 – 63 days 
old allocated were exposed to test concentrations 2 x 10
1
  – 2 x 103.    Those organisms in the 
highest concentration of 2 x 10
3
 ppb sustained 47% mortality, causing the 96 hour LC50 to be 
greater than 2 x 10
3
 ppb (Henry et al. 2004).  Oryzias latipes (Japanese medaka) larvae 6 x 10
3
, 1 
x 10
3
, and 2 x 10
2
 ppb at the respective pHs 7, 8, and 9 (Nakamura et al. 2008).  The average 48 
hour LC50s for Pimephales promelas (fathead minnow) were about 200 ppb for the R-fluoxetine,  
S-fluoxetine, and the racemic-fluoxetine mixtures. 
Table 5.  Exposure times and concentrations of fluoxetine reported to provoke 50% lethality 
(LC50s) in aquatic organisms. 
Exposure time Organism Amount 
(ppb) 
Trend/Response Reference 
24 hours 
Thamnocephalus platyurus 
(Fairy Shrimp) 
8 x 10
2
 Lethality Nalcz-Jawecki 2007 
48 hours 
Chironomus tentans 
(Midge) 
2 x 10
4
 Mortality Brooks et al. 2003b 
48 hours 
Hyalella azteca 
(Scud) 
> 4 x 10
4
 Mortality Brooks et al. 2003b 
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(Table 5 continued) 
Exposure time Organism 
Amount 
(ppb) 
Trend/Response Reference 
48 hours 
Ceriodaphnia dubia 
(Water Flea) 
5 x 10
2
 Increase in Mortality Henry et al. 2004 
48 hours 
Ceriodaphnia dubia 
(Water Flea) 
2 x 10
2
 Mortality Brooks et al.2003b 
48 hours 
Daphnia magna 
(Water Flea) 
8 x 10
2
 Mortality Brooks et al. 2003b 
48 hours 
Pimephales promelas 
(Fathead Minnow) 
7 x 10
2
 Mortality Brooks et al. 2003b 
48 hours 
Pimephales promelas 
(Fathead Minnow) 
~ 2 x 10
2
 Mortality Stanley et al. 2007 
48 hours 
Oryzias latipes 
(Japanese Medaka) 
9 x 10
3
 Mortality Brooks et al. 2003b 
48 hours 
Oncorhynchus mykiss 
(Rainbow Trout) 
2 x 10
3
 Mortality 
FDA-CDER 1996; 
Eli Lilly and 
Company 2005 
96 hours 
Ceriodaphnia dubia 
(Water Flea) 
3 x 10
2
 Mortality Brooks et al. 2003b 
96 hours 
Daphnia magna 
(Water Flea) 
9 x 10
2
 Mortality Brooks et al. 2003b 
96 hours 
Cyprinodon variegatus 
(Sheepshead Minnow) 
> 2 x 10
3
 Mortality (47%) Winder et al. 2009 
96 hours 
Pimephales promelas 
(Fathead Minnow) 
8 x 10
2
 Mortality Brooks et al. 2003b 
96 hours 
Oryzias latipes 
(Japanese Medaka) 
2 x 10
3
 
 
Eli Lilly and 
Company 2005 
96 hours 
Oryzias latipes 
(Japanese Medaka) 
6 x 10
3
 
pH 7 
 
Nakamura et al. 2008 
1 x 10
3
 
pH 8 
2 x 10
2
 
pH 9 
 
Fluoxetine enduced endpoints associated with mortality and/or survival (Table 6).  The 
24 hour LC50 of 600 ± 200 ppb for Spirostomum ambiguum (protozoan) was based on spherical 
deformation and autolysis.  The 24 hour EC50 of 400 ± 100 was based on different deformations 
of morphological changes such as shortening, bending of the cell, etc (Nalcz-Jawecki 2007).  
Juvenile Cyprinodon variegatus (sheepshead minnow) 43 – 63 days old allocated 2000 ppb 
sustained 47% mortality, resulting in the 96 hour LC50 greater than2000 ppb, LOEC 2000 ppb, 
and NOEC 1000 ppb. In concentrations 0, 50, 300, 500, 1000 ppb mortality remained greater 
than or equal to 13% (Winder et al. 2009).   Ceriodaphnia dubia (water flea) suffered 100% 
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mortality in 2000 ppb after 7-8 days.  Introduction to 90 ppb secured 0% mortality.  The median 
concentration of 400 ppb showed a decrease in survivorship (test concentration 20 – 3000 ppb) 
(Henry et al. 2004). 
Table 6.  Exposure times and concentrations of fluoxetine reported to provoke the endpoints 
associated with mortality or survivorship of aquatic organisms. 
Organism Response Endpoint Dose 
(ppb) 
Trend Exposure 
time 
Referenc
e 
Spirostomum 
ambiguum 
(Protozoan) 
Deformation 
and Autolysis 
LC50 600  24 hours 
Nalcz-
Jawecki 
2007 
Spirostomum 
ambiguum 
(Protozoan) 
Deformation LC50 400  24 hours 
Nalcz-
Jawecki 
2007 
Ceriodaphnia 
dubia 
(Water Flea) 
Mortality No effect 90 No effect 7-8 days 
Henry et al. 
2004 
Mortality 
 
2000 Decrease  (100%)  
Survivorship 
 
400 Decrease  
Cyprinodon 
variegatus 
(Sheepshead 
Minnow) 
Mortality 
NOEC 1000 
 
96 hours 
Winder et 
al. 2009 
LOEC 2000  
Pimephales 
promelas 
(Fathead 
Minnow) 
Survivorship 
R-FLX 
NOEC 100 
Decrease 
7 days 
Stanley et 
al. 2007 
LOEC 200  
Pimephales 
promelas 
(Fathead 
Minnow) 
Survivorship 
Rac-FLX 
NOEC 100 
Decrease 
7 days 
Stanley et 
al. 2007 
LOEC 200  
Pimephales 
promelas 
(Fathead 
Minnow) 
Survivorship 
S-FLX 
NOEC 50 
Decrease 
7 days 
Stanley et 
al. 2007 
LOEC 100  
 
Sublethal Effects 
Biological diversity of pharmacodynamics, pharmacokinetics, and physiology may 
produce unanticipated effects on organisms. Modification of the reproductive, immune, and 
central nervous systems can alter hormones, development, and behavior that have not been 
anticipated for non-target species (Fent et al. 2006).   
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Ethinyl estradiol affects fecundity.  Exposure to EE2 caused aquatic organisms to 
experience changes in fecundity (Table 7).  Danio rerio (zebrafish) frys 2 dph acquired had a 
reduced mean egg production (Lin and Janz 2006). Adult Danio rerio (zebrafish) 223 dpf 
showed a decrease in total number of eggs (Nash et al. 2004). Decreased egg production per 
gram of females was observed in Tautogolabrus adspersus (cunner) (Gutjahr-Gobell et al. 2006).  
The total number of eggs of Pimephales promelas (fathead minnow) adults decreased after EE2 
exposure (Brian et al. 2007). An F1 generation study of Pimephales promelas (fathead minnow) 
less than24 hpf embryos exposed for 301 dph showed a decrease number of eggs per female 
breeding day (Lange et al. 2001).   
The number of eggs per pair of Pimephales promelas (fathead minnow) 6-11 months old, 
increased at 1 x 10
-4
 and 1 x 10
-3
 ppb; no eggs were produced in 1 x 10
-1
 ppb.  Effects on 
fertilization caused an NOEC and LOEC at 3 x 10
-3
 ppb and 8 x 10
-4
 ppb respectively. The 
lowest concentration effecting progeny was 1 x 10
-4
 ppb (Pawlowski et al. 2004). 
In one experiment, 15 dpf Danio rerio (zebrafish) larvae were exposed to 1 x 10
-2
 ppb 
during different life stages.  Based on fertilization success those exposed at 15 and 72 dpf were 
not affected.  The only significant time period was 43 dpf in which fertilization decreased; 
additionally the mean number of eggs reported was significantly decreased.  In another study, 15 
dpf organisms were exposed for 28 days at different concentrations resulting in concentration 
dependent reduction of fertilization success with an NOEL of 2 x 10
-3
 ppb and an LOEL of 3 x 
10
-3
 ppb; the mean number of eggs per female per day was not significantly affected (Maack and 
Segner 2004). Based on progeny counts of Nitocra spinipes (harpacticoid copepod), a decrease 
in reproduction was observed (Breitholtz and Bengtsson 2001). An F1 generation study of 
Cyprinodon variegates (sheepshead minnow) embryos showed a decrease in reproduction based 
on progeny/ number of eggs per female reproductive day (Zillioux et al. 2001).  
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Increase in eggs per spawning Pimephales promelas (fathead minnow) based on gamete 
production in eggs (Brian et al. 2007).  Adult Pimephales promelas (fathead minnow) 
relinquished spawning completely after 28 days in less than1 x 10
-2
 ppb (Lange et al. 2001).  
Decrease in reproduction frequency and fertility of Daphnia magna (water flea) neonates 
exposed for 25 days (Goto and Hiromi 2003). Oryzias latipes (Japanese medaka) had a decrease 
in fecundity, decreased number of spawning females, and decreased fertilization rate (Ma et al. 
2005).  Based on the average number of eggs per day per pair a decrease in 
reproduction/fecundity of Oryzias latipes (Japanese medaka) was observed (Seki et al. 2002). 
Reduction in the percent of Oryzias latipes (Japanese medaka) participating in copulatory 
activity was reported (Balch et al. 2004). Oryzias latipes (Japanese medaka) embryos less than or 
equal to 8 hpf showed increased germ cells counts; gamete production in gonads after injections 
produced a 10 dph NOEC of 1 x 10
-4
 μg/egg and LOEC of 5 x 10-4 μg/egg (Hano et al. 2005).  In 
a generational effluent study of immature Pomatoschistus minutus (sand goby), 6 x 10
-3
 ppb 
decreased the percentage of males nesting, percentage of pairs breeding, and overall number of 
pairs (Robinson et al. 2003). 
Table 7.  Exposure times and concentrations of ethinyl estradiol reported to provoke the 
endpoints associated with fecundity or reproduction of aquatic organisms. 
Organism Measured 
Response 
End 
point 
Dose 
(ppb) 
Trend Exposu
re time 
Reference 
Daphnia magna 
(Water Flea) 
Reproduction 
Frequency 
NOEC 5 x 10
2
 Decrease 25 days 
Goto and 
Hiromi 2003 
Nitocra spinipes 
(Harpacticoid 
Copepod) 
Reproduction/ 
Progeny counts 
NOEC 5 x 10
1
 Decrease 
15-18 
days 
Breitholtz 
and 
Bengtsson 
2001 
Cyprinodon 
variegates 
(Sheepshead Minnow) 
Reproduction/ 
Progeny counts 
NOEC 
2 x 10
-2
 
 
Decrease in 
eggs per 
female 
F1 generation 
study 73 days 
 
Zillioux et al. 
2001 
LOEC 
9 x 10
-2
  
–  
1 
 
MATC 
 
6 x 10
-2
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(Table 7 continued) 
Organism Measured 
Response 
End 
point 
Dose 
(ppb) 
Trend Exposu
re time 
Reference 
(Danio rerio 
(Zebrafish) 
Fertilization 
Success 
No 
effect 
1 x 10
-2
  
15 dpf Maack and 
Segner 2004 
72 dpf 
Danio rerio 
(Zebrafish) 
Fertilization 
Success 
NOEL 2 x 10
-3
 
Decrease 
 
*Mean number 
of eggs per 
female per day 
not significant 
28 days 
 
 
 
Maack and 
Segner 2004 
LOEL 3 x 10
-3
  
Danio rerio 
(Zebrafish) 
Gamete 
Production 
LOEL 1 x 10
-3
 
Decrease in 
mean egg 
production 
58 days 
Lin and Janz 
2006 
Danio rerio 
(Zebrafish) 
Gamete 
Production 
NOEL 5 x 10
-3
 
Decrease in 
total number 
of eggs 
10 days 
 
 
Nash et al. 
2004 
LOEL 5 x 10
-2
  
Oryzias latipes 
(Medaka) 
Fecundity 
NOEC 3 x 10
-1 
Decrease 
based on 
average 
number of 
eggs per day 
per pair 
0-21 
days 
Seki et al. 
2002 
LOEC 5 x 10
-1
  
Oryzias latipes 
(Medaka) 
Fecundity LOEL 1 x 10
-1
 
Decreased 
 
*Decreased 
number of 
spawning 
females 
 
*Decreased 
fertilization 
rate 
28 days 
Ma et al. 
2005 
Oryzias latipes 
(Medaka) 
Gamete 
Production 
NOEC 
1 x 10
-4 
μg/egg 
Increase in 
germ cells 
counts 
10 dph 
 
Hano et al. 
2005 
LOEC 
5 x 10
-4
 
μg/egg 
 
Oryzias latipes 
(Medaka) 
Mounting/ 
Copulation/ 
Intercourse 
NOEL 2 x 10
-3 
Decrease 121.76 – 
182.64 
days 
Balch et al. 
2004 LOEL 1 x 10
-2
  
Pimephales promelas 
(Fathead Minnow) 
Gamete 
Production 
NOEC 
1 x 10
-3
 
– 
2 x 10
-3
 
Decrease in 
total number 
of eggs 
21 days 
Brian et al. 
2007 
Pimephales promelas 
(Fathead Minnow) 
Gamete 
Production 
NOEC 5 x 10
-4
 
Increase in 
eggs per 
spawning 
21 days 
Brian et al. 
2007 
Pimephales promelas 
(Fathead Minnow) 
Number 
Spawning 
NOEL 
6 x 10
-4 
and 
2 x 10
-3
 
 21 day 
Brian et al. 
2007 
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(Table 7 continued) 
Organism Measured 
Response 
End 
point 
Dose 
(ppb) 
Trend Exposu
re time 
Reference 
Pimephales promelas 
(Fathead Minnow) 
Fertilization 
NOEC 3 x 10
-3
 
 21 days 
Pawlowski et 
al. 2004 
LOEC 8 x 10
-4
 
Number of eggs 
per pair 
 
1 x 10
-4 
1
 x 10
-3
 
Increase 
 No eggs produced  1 x 10
-1
  
Progeny LOEC 1 x 10
-4
  
Pimephales promelas 
(Fathead Minnow) 
Spawning 
 
NOEC < 1 x 10
-2
 
Total Lack of 
spawning 
28 days 
Lange et al. 
2001 
Pimephales promelas 
(Fathead Minnow) 
Progeny 
(number of eggs 
per female 
breeding day) 
NOEC ≥ 8 x 10-4 Decrease 301 dph 
 
 
 
Lange et al. 
2001 LOEC > 8 x 10
-4
  
Pomatoschistus 
minutus (Sand goby) 
%  Males nesting 
 6 x 10
-3
 
Decrease 
gener-
ational 
effluent 
study 
Robinson et 
al. 2003 
%  Pairs breeding Decrease 
Overall number 
of pairs 
Decrease 
Tautogolabrus 
adspersus (Cunner) 
Egg Production 
NOEL 5 x 10
2
 
Decrease per 
gram female 
 
*Increase of 
egg viability at 
0.05 mg/kg 
14 days 
 
 
 
Gutjahr-
Gobell et al. 
2006 
LOEL 3 x 10
3
  
Dreissena 
polymorpha 
(Zebra Mussels) 
Males 
Spawning 
 
5 x 10
-7
 
– 
5 x10
-4
 
M of 
FLX 
spawned 
within 
the first hour 
 
Fong 1998 
Dreissena 
polymorpha 
(Zebra Mussels) 
Females 
Spawning 
LOEC 
200 E-5 
P 
5 x 10
-6
 
and 10 
-5
 
M of 
FLX 
 
 
Fong 1998 
Dreissena 
polymorpha 
(Zebra Mussels) 
Males 
Sperm Motlility 
 
5 x 10
-3
 – 
5 x 10
-5
 
M of 
FLX 
not motile 
*But, sperm 
recovered 
motility 
when placed in 
fresh lake 
water 
 
Fong 1998 
Dreissena 
polymorpha 
(Zebra Mussels) 
Males 
Growth and 
Development  
1 x 10
-3
 
M of 
FLX 
looked 
unhealthy  
Fong 1998 
*Additionally observed trends 
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Fluoxetine affects fecundity.  Exposure to FLX caused changes in the fecundity of 
aquatic organisms (Table 8).  Reproduction effects modulated by serotonin vary between 
different phyla (Fent et al. 2006).   In vivo exposure of 0.5 mg/mL of FLX for 1 hour induced 
egg laying in Caenorhabditis elegans (nematoda roundworm) (Dempsey et al. 2005).  
Chironomus tentans (diptera: chironomidae) egg clutches exposed to 6 ppb of Fluoxetine 
contained significantly more eggs (515 ± 194) than the control (316 ± 214) (Williams and 
Herrup 1988). Ceriodaphnia dubia (water flea) exposed for 7 days had LOEC 400 and NOEC 90 
ppb for both the reduction in number of broods produced and the reduction of neonates (Henry et 
al. 2004). A similar NOEC of 60 ppb based on reduced number of neonates in was observed by 
Brooks et al. (2003).   
Fluoxetine administered at 1 ppb amplified 5-HT and induced stimulation of parturition 
of Sphaerium straitium (fingernail clam) (Fong et al. 1998). Procambarus clarkii (red swamp 
crayfish) injected with 15 μg/g body weight fluoxetine in vivo at 1, 5, 10, and 15 days, increased 
ovarian index and oocyte size, and amplified 5-HT-induced effects (Kulkarni et al. 1992).  
Serotonin promotes oocyte maturation in Oryzias latipes (Japanese medaka) (Iwamatsu et 
al. 1993) and in some bivalves and crustaceans as well as induced spawning (Fong 2001) at 50 
nM in males and 5 µM in female Dresissena polymorpha (Zebra mussel) (Fong 1998) and at 1 
ppb in vivo for Macoma balthica (Baltic clam) and created an extension of spawning season 
(Honkoop et al. 1999).   
Chironomus riparius (midge) showed no effect in reproduction measured concentrations 
up to 60 ppb (Péry et al. 2008). Oryzias latipes (Japanese medaka) exposed for 4 weeks to 
fluoxetine at concentrations of 100–5000 ppb, had no effect on vitellogenin plasma content, 
plasma steroids, fecundity, egg fertilization or hatching rate (Foran et al. 2004). This indicates 
that FLX concentrations up to 5 ppb do not impair reproduction in this fish. A significant 
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decrease of reproduction was observed in Potamopyrgus antipodarum (snail) at 10 ppb with a 
reproduction success LOEC of 5 x 10
-2
 ppb (Péry et al. 2008). Fecundity of Ceriodaphnia dubia 
(water flea) was decreased by fluoxetine treatments of 200 ppb (Brooks et al. 2003 a; b). 
However, C. dubia fecundity was significantly increased after 7 day exposure of 60 ppb 
fluoxetine (Brooks et al. 2003b) producing an NOEC of 60 ppb and an LOEC of 100 ppb 
(Brooks et al. 2003).  Doses of FLX (1400, 2800, 5600, 11200, 22400 ppb) appeared to stimulate 
reproduction in Hyalella azteca (scud) (Brooks et al. 2003 a, b).  It is assumed that enhanced 
fecundity may be brought about by increased serotonin levels (Brooks et al. 2003b).  Studies 
indentified that minimal quantities may trigger advanced fecundity; however, increased egg and 
neonate production is often associated with reduced egg and neonate body size (Bodar et al. 
1988; Ebert 1993). 
Table 8. Exposure times and concentrations of fluoxetine reported to provoke the endpoints 
associated with fecundity or reproduction of aquatic organisms.   
Organism Measured 
Response 
End 
point 
Dose 
(ppb) 
Trend Exposu
re time 
Reference 
Caenorhabdtis 
elegans  
(Nematoda 
Roundworm) 
Egg laying 
 
 
0.5 mg/mL 
of FLX 
Induce 1 hour 
Dempsey et 
al. 2005 
Chironomus 
tentans  
(Diptera: 
Chironomidae) 
Egg clutches 
 
 6 of FLX 
Significantly 
more eggs than 
the control 
 
Williams 
and Herrup 
1988 
Ceriodaphnia dubia 
(Water Flea) 
Progeny counts/ 
Number 
NOEC 
9 x 10
1
 
 
Decrease 
 
*Reduced 
number of 
neonates 
 
*Reduced 
number of 
broods 
7 days Henry et al. 
2004 
LOEC 4 x 10
2
   
Ceriodaphnia dubia 
(Water Flea) 
Number of 
neonates 
NOEC 6 x 10
1
 Decrease  
Brooks et al. 
2003 
Ceriodaphnia dubia 
(Water Flea) 
Fecundity 
 
2 x 10
2
 Decrease  
Brooks et al. 
2003 a; b 
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(Table 8 continued) 
Organism Measured 
Response 
End 
point 
Dose 
(ppb) 
Trend Exposu
re time 
Reference 
Ceriodaphnia dubia 
(Water Flea) 
Fecundity 
NOEC 6 x 10
1
 Increase 
7 days 
Brooks et al. 
2003 a; b 
LOEC 1 x 10
2
  
Chironomus riparius 
(Midge) 
Reproduction 
No 
effect 
6  x 10
1
 
  
Péry et al. 
2008 
Hyalella azteca 
(Scud) 
Reproduction 
 
1 x 10
3
 
 
3 x 10
3
 
 
6 x 10
3
 
 
1 x 10
4
 
 
2 x 10
4
 
Stimulates 
 
Brooks et al. 
2003 a,b 
Dresissena 
polymorpha  
(Zebra Mussel) 
Spawning 
 
50 Nm male 
 
5 µM in 
female 
Induced 
Spawning 
 
*Promotes 
oocyte 
maturation 
 
Fong 1998 
Macoma balthica 
(Baltic Clam) 
Spawning 
 
1 
Induced 
 
*Extension of 
spawning 
season 
 
Honkoop et 
al. 1999 
Potamopyrgus 
antipodarum  
(Snail) 
Reproduction 
 
1 x 10
-1
 Decrease 
 
Péry et al. 
2008 
Potamopyrgus 
antipodarum  
(Snail) 
Reproduction 
Success 
LOEC 5 x 10
-1
 
  
Péry et al. 
2008 
Procambarus clarkia 
(Red Swamp 
Crayfish) 
Ovarian index 
and oocyte size  
15 μg/g 
body weight 
Increase 
 
*Amplified 5-
HT-induced 
effects 
1, 5, 10, 
and 15 
days, 
Kulkarni et 
al. 1992 
Sphaerium straitium 
(Fingernail Clam) 
Parturition 
 
1 
Induced 
 
*Amplified 5-
HT 
 
Fong et al. 
1998 
Oryzias latipes 
(Japanese Medaka) 
Oocyte 
maturation  
Serotonin 
  
Iwamatsu et 
al. 1993 
Oryzias latipes 
(Japanese Medaka) 
Vitellogenin 
plasma content 
No 
effect 
1 x 10
2
 
– 
5 x 10
2
 
 
4 
Weeks 
Foran et al. 
2004 
Plasma steroids 
Fecundity 
Egg fertilization 
Hatching rate 
*Additionally observed trends 
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Ethinyl estradiol affects growth and development.  Aquatic organisms exposed to EE2 
exibited changes in normal growth and development (Table 9).  The following organisms 
showed a decrease in whole body growth based on length, and weight:  Oryzias latipes (medaka) 
(5 μg/organism) (Papoulias et al. 2001), Pomatoschistus minutus (sand goby) (6 x 10-3 ppb) 
(Robinson et al. 2003), and Danio rerio (zebrafish) (58 day LOEC 1 x 10
-2
 ppb) (Lin and Janz 
2006).  
A decrease in length in Danio rerio (zebrafish) (Andersen et al. 2004) and in 
Dicentrarchus labrax (sea bass) (Blazquez et al. 1998). 
Increased length was recorded in Acartia tonsa (calanoid copepod) (Andersen et al. 
2004), Oncorhynchus tshawytscha (chinook salmon) (Piferrer and Donaldson 1992), and in 
Salvelinus namycush (lake trout) (Werner et al. 2003).  
Decrease in weight in Anguilla Anguilla (common eel) (Versonnen et al 2004) and in 
Carassius auratus (goldfish) (Martyniuk et al. 2006).   Bogers et al. (2006) observed an increase 
in whole body weight in Danio rerio (zebrafish). 
A decrease in length and weight was observed in fathead minnows exposed for 37 days.  
Additional exposure produced effects on length. Those exposed until 301 days post hatch 
showed no effect on length (Lange et al. 2001). 
Danio rerio (zebrafish) were reported to have a decrease in weight but an increase in 
length (Lin and Janz 2006). Decrease in progeny developmental stage in Danio rerio (zebrafish) 
based on swim-up breeding trial begun 240 days post hatch after 6 months recovery with no 
exposure, a decrease in stage development of the progeny (offspring) was found (Lin and Janz 
2006).  
Acartia tonsa (calanoid copepod) exposed for 5 days showed a decrease in larval 
development (Andersen et al. 2001). Hyalella azteca (scud) exposed to 10 ppb exhibited a 
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decrease in sexual development of Gnathopod (modified jaw) but showed an increase in length 
of antenna (Vandenbergh et al. 2001).  Oncorhynchus mykiss (rainbow trout) (Verslycke et al. 
2002) and Acipenser flvescens (lake sturgeon) showed an increase in the weight of the gonad in 
relationship to body.  Also observed was an increase in liver weight in relationship to body in 
Acipenser flvescens (lake sturgeon) (Palace et al. 2001), Oncorhynchus mykiss (rainbow trout) 
(Verslycke et al. 2002), and Ictalurus punctuates (channel catfish) (Nimrod and Benson 1996). 
Table 9.  Exposure times and concentrations of ethinyl estradiol reported to provoke the 
endpoints associated with growth and development of aquatic organisms. 
Organism Measured 
Response 
Exposure 
time 
End 
point 
Dose 
(ppb) 
Trend Reference 
Acartia tonsa 
(Calanoid Copepod) 
Larval 
Development 
5 days EC50 9 x 10
1
  
Anderson et al. 
2001 
Acartia tonsa 
(Calanoid Copepod) 
Larval 
Development 
5 days 
 
 
4 x 10
1
   
– 2 x 
10
2
 
Decrease 
Anderson et al. 
2001 
Acartia tonsa 
(Calanoid Copepod) 
Length 18 days NOEC 
3 x 10
-
2
 
Increase 
Anderson et al. 
2004 
Hyalella azteca 
(Scud) 
Sexual 
Development 
of Gnathopod 
(modified jaw) 
28 days 
 
1 x 10
1
 Decrease 
Vandenbergh et 
al. 2003 
Hyalella azteca 
(Scud) 
Length of Antenna 28 day NOEC 1 x 10
1
 Increase 
Vandenbergh et 
al. 2003 
Anguilla Anguilla 
(Common Eel) 
Weight 9 day NOEL 1 x 10
1
 Decrease 
Versonnen et al. 
2004 
Anguilla Anguilla 
(Common Eel) 
Weight 15 day NOEL 1 nM Decrease 
Versonnen et al. 
2004 
Acipenser flvescens  
(Lake Sturgeon) 
Weight of Gonads  25 days 
6 x 10
-
2 
 –  
1 
Increase Palace et al. 2001 
Acipenser flvescens 
 (Lake Sturgeon) 
 
Weight of Liver  25 days 
1 x 10
-
2 
  –  
6 x 10
-
2
 
Increase Palace et al. 2001 
Carassius auratus 
(Goldfish) 
Weight 15 days NOEL 1 nM Decrease 
Martyniuk et al.  
2006 
Danio rerio 
(Zebrafish) 
Length 
and 
Weight 
58 days LOEC 
1 x 10
-
2
 
Decrease 
Lin and Janz 
2006 
Danio rerio 
(Zebrafish) 
Weight 
40 days 
NOEC 
3 x 10
-
2
 
Decrease 
Andersen et al. 
2004 
Length LOEC 
3 x 10
-
2
 
Decrease  
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(Table 9 continued) 
Organism Measured 
Response 
Exposure 
time 
End 
point 
Dose 
(ppb) 
Trend Referenc
e 
Danio rerio 
(Zebrafish) 
Weight 30 days  
1 x 10
-3
  
–  
8 x 10
-3
 
Increase 
Bogers et 
al. 2006 
Danio rerio 
(Zebrafish) 
Length 
58 days 
NOEC 1 x 10
-2
 Increase 
Lin and 
Janz 2006 
Weight NOEC 1 x 10
-2
 Decrease  
Danio rerio 
(Zebrafish) 
Developmental stage 
of  Progeny 
58 days LOEC 1 x 10
-2
 Decrease 
Hill and 
Janz 2003 
Dicentrarchus 
labrax 
 (Sea Bass) 
Length 200 days LOEC 1x 10
4
 Decrease 
Blazquez 
et al. 1998 
Ictalurus 
punctuates 
(Channel 
Catfish) 
Weight of Liver 7 days 
 
7 x 10
2
 Increase 
Nimrod 
and 
Benson 
1996 
Oncorhynchus 
mykiss 
 (Rainbow Trout) 
Weight of Gonads 7 days  
1x 10
3
  
–  
5x 10
3
 
Increase 
Verslycke 
et al. 2002 
Oncorhynchus 
mykiss 
 (Rainbow Trout) 
Weight of Liver 7 days 
 
1x 10
4
 
and 
3 x 10
4
 
Increase 
Verslycke 
et al. 2002 
Oncorhynchus 
tshawytscha 
(Chinook 
Salmon) 
Length 
184 days 
post hatch 
 
NOEC 4 x 10
2
 Increase 
Piferrer 
and 
Donaldson 
1992 
Oryzias latipes 
(Medaka) 
Length and Weight 105 days  
5 μg/ 
organism 
Decrease 
Papoulias 
et al. 2001 
Pimephales 
promelas 
(Fathead 
Minnow) 
Length and Weight 37 days  
1 x 10
-2
 Decrease 
Lange et 
al. 2001 
1   
Pimephales 
promelas 
(Fathead 
Minnow) 
Length 
56 days post 
hatch 
LOEC 3 x 10
-3
 Decrease 
Lange et 
al. 2001 
Pimephales 
promelas 
(Fathead 
Minnow) 
Length 
301 days 
post hatch 
 
NOEC 
and 
LOEC 
> 8 x 10
-4
 Decrease 
Lange et 
al. 2001 
Pomatoschistus 
minutus 
 (Sand Goby) 
Length and Weight 
0-213.08 
days 
 6 x 10
-3
 Decrease 
Robinson 
et al 2003 
Salvelinus 
namycush 
 (Lake Trout) 
Length 21 days 
NOEC 4 x 10
3
 
Increase 
 
Werner et 
al. 2003 
LOEC 
2 x 10
-2
  
–  
4 
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Fluoxetine affects growth and development.  Aquatic organisms exposed to FLX 
exhibited changes in normal growth and development (Table 10).  Chironomus riparius did not 
exhibit any significant effects on growth for concentrations up to 6000 ppb in the sediment 
(Nentwig 2006). The median effective concentration (MICs), the lowest concentration of an 
antimicrobial that will inhibit the visible growth of a microorganism after overnight incubation, 
were established for the following: S. capricornutum (green algae), Chaetomium globosum 
(fungus), Aspergillus flavus (mold), Pseudomonas acidovorans (soil bacteria), Azotobacter 
chroococcum (N-fixing bacteria), and Nostoc sp. (blue-green algae) (Eli Lilly and Company 
2005). The growth of Hyalella azteca (Scud) produced an NOEC of 30 ppb and an LOEC of 100 
ppb (Péry et al. 2008).  Brooks et al. (2003) found an LOEC of 6000 ppb.  
Although F1 generation Daphnia magna (water flea) showed much more pronounced 
effects in the sense that they were longer length, they still had the same NOEC and LOEC as the 
F0 generation. A slight decrease in length was observed at 3 ppb. At this concentration the 
organisms’ length was between that of the NOEC and LOEC; however, this concentration was 
not significant because the length of the organisms in the NOEC (10 ppb) was close to those in 
the control (Péry et al. 2008).  
Based on growth, Chironomus tentans (midge) had an LOEC of 1000 ppb (Brooks et al. 
2003). Pimephales promelas (fathead minnow) exposed to FLX exhibited decreased growth and 
feeding rates (Stanley et al. 2007).   
Female Gambusia affinis (western mosquitofish) were significantly longer and larger 
(wet weight) than males at the end on the 91 day exposure period.  The number of females 
remained 49 – 54% in each treatment and the control.  Few fish had enlogated anal fins; 
however, neither control nor exposed fish developed a mature gonopodium with completely 
formed hooks.  Sexual maturity was delayed in female and males from the juvenile stage (59 
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days) to the adult stage (159 days) as indicated by the development of a black spot (female) and 
elongated anal fin (males).  In this experiment the number of females in control and all 
treatments was 54 -57%.  At 70 ppb, the number of organisms developing a black spot on the 
posterior portion of the abdomen was significantly lower as well as the number growing an 
elongated anal fin (Henry and Black 2008). 
Table 10. Exposure times and concentrations of fluoxetine reported to provoke the endpoints 
associated with growth and development of aquatic organisms. 
Organism Measured 
Response 
End point Dose 
(ppb) 
Trend Exposure 
time 
Reference 
Aspergillus flavus 
(Mold) 
Growth 
Rate 
MIC 6 x 10
4
   
Eli Lilly and 
Company 
2005 
Azotobacter 
chroococcum  
(N-fixing Bacteria) 
Growth 
Rate 
MIC 6 x 10
4
   
Eli Lilly and 
Company 
2005 
Chaetomium 
globosum  
(Fungus) 
Growth 
Rate 
MIC 6 x 10
4
   
Eli Lilly and 
Company 
2005 
Pseudomonas 
acidovorans 
(Soil Bacteria) 
Growth 
Rate 
MIC 1 x 10
6
   
Eli Lilly and 
Company 
2005 
Nostoc sp. 
 (Blue-Green 
Algae) 
Growth 
Rate 
MIC 3 x 10
5
   
Eli Lilly and 
Company 
2005 
S. capricornutum 
(Green Algae) 
Growth 
Rate 
MIC 3 x 10
1
   
Eli Lilly and 
Company 
2005 
Chironomus 
riparius 
Growth No effect 6 x 10
3
   
Nentwig 
2006 
Chironomus 
tentans (Midge) 
Growth LOEC 1 x 10
3
   
Brooks et al. 
2003 
Hyalella azteca 
(Scud) 
Growth 
NOEC 3 x 10
1
   
Péry et al. 
2008 
LOEC 1 x 10
2
   
LOEC 6 x 10
3
   
Brooks et al. 
2003 
Daphnia magna 
(Water Flea) 
(F0 and F1 
generation) 
Length 
NOEC 1 x 10
1
 
F1 generation 
longer length 
21 days 
Péry et al. 
2008 
LOEC 3 x 10
1
   
Gambusia affinis 
(Western 
Mosquitofish) 
Growth, 
length and 
wet weight 
 
5 x 10
-2 
5 x 10
-1
 
 5 
Females 
significantly 
longer and 
larger 
91 days 
Henry and 
Black 2008 
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(Table 10 continued) 
Organism 
Measured 
Response 
End point 
Dose 
(ppb) 
Trend 
Exposure 
time 
Reference 
Gambusia affinis 
(Western 
Mosquitofish) 
Black spot 
on the 
posterior 
portion of 
the 
abdomen 
(females) 
 
70 
Decrease 
 
 
100 days 
Henry and 
Black 2008 
Number 
growing an 
elongated 
anal fin 
(males) 
 
70 
Decrease 
 
49-59 days 
No 
response 
0, 7, 70 
Not different 
from control 
73-100 days 
Pimephales 
promelas 
 (Fathead Minnow) 
Growth 
R-FLX 
NOEC 1 x 10
2
 
No effect 7 days 
Stanley et al. 
2007 
LOEC 2 x 10
2
 
Pimephales 
promelas  
(Fathead Minnow) 
Growth 
Rac-FLX 
NOEC 1 x 10
1
 
Decrease 7 days 
Stanley et al. 
2007 
LOEC 5 x 10
1
 
Pimephales 
promelas 
 (Fathead Minnow) 
Growth 
S-FLX 
NOEC 1 x 10
1
 
Decrease 7 days 
Stanley et al. 
2007 
LOEC 5 x 10
1
 
Pimephales 
promelas 
 (Fathead Minnow) 
Feeding 
Rates 
R-FLX 
NOEC 1 x 10
2
 
Decrease 7 days 
Stanley et al. 
2007 
LOEC 2 x 10
2
 
Pimephales 
promelas  
(Fathead Minnow) 
Feeding 
Rates Rac-
FLX 
NOEC 5 x 10
1
 
Decrease 7 days 
Stanley et al. 
2007 
LOEC 1 x 10
2
 
Pimephales 
promelas  
(Fathead Minnow) 
Feeding 
Rates 
S-Flx 
NOEC 1 x 10
1
 
Decrease 7 days 
Stanley et al. 
2007 
LOEC 5 x 10
1
 
 
Impacts on Nontarget Organisms 
The U.S. Geological Survey has established a baseline for pharmaceuticals and personal 
care products as ―emerging pollutants‖ in the United States (Kolpin et al. 2002).  The baseline 
states that these contaminants have to potential to affect the health and welfare of aquatic 
ecosystems and humans (Khetan et. al 2007).  Pharmaceuticals with modes of action depending 
upon signal transduction, cell division, and key metabolizing enzymes can be hazardous to 
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nontarget organisms that possess these necessary human features to carry out the drugs function 
(Nelson et al. 1996).  If nontarget organisms lack the necessary attributes for the specified mode 
of action, disparate modes of action will transpire resulting in unanticipated effects (Fent et al. 
2006).  
Biochemical reactions that have been identified in humans may not justify irregularities 
observed in animals.  Because of the limitations in understanding biochemical signaling 
pathways, drugs also act by other routes and on nontargeted tissues and organisms.  Even if the 
pharmaceutical were capable of reacting with a single type of receptor, the tissue distribution of 
the receptor may not be fully understood.  With this in mind, potential actions and biochemical 
effects on nontarget aquatic ecosystems are not entirely realized or identified (Daughton and 
Ternes 1999). Although these chemicals are present in extremely low concentrations, this does 
not belittle their potential to cause harm to the environment.  Pharmaceuticals are designed to 
produce a response at low levels (Halford 2008).  Minute amounts of chemicals, typically 
considered safe because they occur at trace amounts, can elicit unanticipated effects on 
ecosystems as evident by xenobiotics such as DDT and PCBs which have hormone mimicking 
effects on the reproductive systems of organisms at nanograms/L (Colbum and Clement 1992).   
Ethinyl Estradiol Performance in Animals 
The binding affinity for the estrogen receptor in fish is correlated with the relative 
potency of the sex steroid (Papoulias et al. 1999).  Research led by John Sumpter, an 
ecotoxicolgist at England’s Brunel University, linked the presence of the synthetic birth control 
compound 17α-ethinylestradiol to the feminizing phenomenon (Desbrow et al. 1998). In the 
1990s reports from the United Kingdom and the United States fish living downstream from 
wastewater treatment plants exhibited several reproductive abnormalities including but not 
limited to changes in the levels of sex steroids, hermaphroditism, and increased levels of 
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vitellogenin (the female egg yolk precursor) in male fish (Beven et al. 1996; Folmer et al. 1996; 
Harries et al. 1996; Purdom et al. 1994; and Jobbing et al. 1998).  These abnormalities are 
deemed feminization because fish that are genetically male exhibit female sex characteristics 
(Papoulias et al. 1999).  
 Pimephales promelas (fathead minnow) embryos 48-60 hours post fertilization exposed 
106 – 150 days post hatch developed secondary sex characteristics (Parrott and Blunt 2005).  
After injections of EE2 in Oryzias latipes (medaka) embryos less than or equal to 8 hpf exposed 
for 100 dph began to exhibit abnormal morphology of the gonads after injection.  The XY males 
displayed phenotypic female characteristics; ovaries actively produced maturing oocytes in the 
postvitellogenic phase and papillary processes on the anal fin were void (Hano et al 2005).  
Precocious sexual development of genital papillae was observed in juvenile Etheostoma 
caeruleum (rainbow darter) 120 days post hatch and progressively increasing.  Also reported 
with the same endpoints was an increase in imposex/intersex conditions (Elias et al. 2007). 
Mature Oryzias latipes (medaka) about 6 months post hatch manifested an increase in 
morphology of intersex gonads based on testis-ova (Seki et al. 2002). Dicentrarchus labrax (sea 
bass) exposed to 10000 ppb through diet displayed smaller size gonads than control and 
instances of intersex and sterile gonads (Blazquez et al. 1998). Margariscus margarita (pearl 
dace) had a reduction of the developmental stage of ovaries with reduction of vitellogenic 
oocytes (Palace et al. 2006).  
Lai et al. (2002) found that 6 x 10
-3
 ppb of EE2 produced 100% female Danio rerio.   
Tilapia aurea (tilapia) fed 50,000 ppb EE2 for 19 days yielded 100% sex reversal (Nakamura 
and Takahashi 1973; Papoulias et al. 1999). The estimated dosage to produce 50% XY female 
Oryzias latipes (medaka) is 2000 ppb EE2, 6000 ppb estradiol (E2), and 20000 mg/g estrone 
(Yamamoto 1975) in (Papoulias et al. 1999).  Primary germ cell number and gonad size of 
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medaka signify that sex reversal has occurred by about 6 days post hatch (Papoulias et al. 1999).  
Sex reversal demonstrates the plasticity and vulnerability of gonads (Papoulias et al. 1999).  
A decrease in the morphology of testes was observed in Oncorhynchus mykiss (rainbow 
trout) after 62 days (Schultz et al. 2003).  Testes size diminished in relationship to the body of 
Oncorhynchus mykiss (rainbow trout) (Jobling et al. 1996) and in Danio rerio (zebrafish) greater 
than240 days post hatch (Lin and Janz 2006).  
Decrease in renal somatic index, GSI (gonadosomatic indices: gonad weight/body weight 
x 100), and HSI (Hepatomsomatic indices liver weight) were indicated in sexually mature 
Gobiocypris rarus (Chinese rare minnow) 7 months old.  Males were generally more sensitive 
than females (Zha et al. 2007). 
Fewer motile sperm in adult Danio rerio (zebrafish) after 21 days (Santos et al. 2007) 
with an NOEL based on sperm motility of 5 x10
-4
 and an LOEL of 5 x10
-3
. A decreased sperm 
count was observed giving an LOEL of 2 ppb in juvenile Poecilia reticulate (guppy) less than or 
equal to 7 days old; however, a significant increase of the sperm count was observed at 1 x 10
-2
 
ppb (Nielsen and Baatrup 2006). A reduction in number of normal development of tubercles 
(which are features of males) after 21 days in mature Pimephales promelas (fathead minnow) 6-
11 months old instituted an NOEC of 1 x 10
-4
 ppb and an LOEC of 7 x 10
-4
 ppb (Pawlowski et 
al. 2004).  Tubercles of adult male Pimephales promelas (fathead minnow) developed 
abnormally after exposure to EE2 for 21 days.  A decrease in the number of normal developed 
tubercles occurred at 5 x 10
-4
 ppb and 1 x 10
-3
 – 2 x 10-3 ppb.  The lesser concentrations caused a 
higher instance of prominent tubercles.  The higher concentrations caused a decrease in the 
normal shape/prominence of tubercles.  Decrease in normal shape/promincence of tubercles 
NOEC 5 x 10
-4
 ppb; increase in normal shape/prominence of tubercles/size NOEL 5 x 10
-4
 ppb 
(Brian et al. 2007). An NOEL based on the sexual development of the mean number of tubercles 
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in Pimephales promelas (fathead minnow) adults (Bogers et al. 2007).  These studies reaffirm 
what Kidd et al. (2007) conveyed; even at low concentrations, if estrogen is present at a 
measurable concentration feminization has the potential to occur.    
Table 11.  Exposure times and concentrations of ethinyl estradiol reported to provoke the 
endpoints associated with abnormalities of aquatic organisms. 
Organism Measured 
Response 
End 
point 
Dose 
(ppb) 
Trend Exposure 
time 
Reference 
Danio rerio 
(Zebrafish) 
Sex Reversal  6 x 10
-3
 100% females  Lai et al. 2002 
Danio rerio 
(Zebrafish) 
Testes Size  1 x 10
-2
 Decrease >240 dph 
Lin and Janz 
2006 
Danio rerio 
(Zebrafish) 
Sperm motility 
NOEL 5 x 10
-4
 Decrease 21 days Santos et al. 
2007 LOEL 5 x 10
-3
   
Dicentrarchus 
labrax (Sea 
Bass) 
Gonad Size  1 x 10
4
 
Decrease; 
sterile gonads 
200 days 
Blazquez et al. 
1998 
Etheostoma 
caeruleum 
(Rainbow 
darter) 
Sexual 
Development 
of Genital 
Papillae 
NOEC 2 x 10
-2
 No Effect 
21 days 
 
Elias et al. 2007 
LOEC 2 Increase  
Gobiocypris 
rarus (Chinese 
Rare Minnow) 
Size of Kidney LOEC 1 x 10
-3
 Decrease 28 days Zha et al. 2007 
Margariscus 
margarita 
(Pearl dace) 
Develop-
mental Stage 
of Ovaries 
LOEL 5 x 10
-3
 Decrease 882.76 days 
Palace et al. 
2006 
Oncorhynchus 
mykiss 
(Rainbow 
Trout) 
Weight of 
Testes 
 2 x 10
-3
 Decrease 21 days 
Jobling et al. 
1996 
Oryzias latipes 
(Medaka) 
Abnormal 
Morphology of 
Gonads 
NOEC 
1 x 10
-4 
μg/egg 
 
100 dph 
Hano et al. 
2005 
LOEC 
5x 10
-4
  
μg/egg 
 
Oncorhynchus 
mykiss 
(Rainbow trout) 
Morphology of 
Testes 
LOEC 1 Decrease 62 day 
Schultz et al. 
2003 
Oryzias latipes 
(Medaka) 
Morphology of 
Intersex 
Gonads 
NOEC 3 x 10
-2
 Increase 21 days 
Seki et al. 2002 
LOEC 6 x 10
-2
   
Oryzias latipes 
(Medaka) 
Sex Reversal –  
estimated dose 
to produce 
50% XY 
females 
EE2 2 x 10
3
 
  
Yamamoto 
1975 in 
Papoulias et al. 
1999 
Estradiol 
(E2) 
6 x 10
3
 
Estrone 
20,000 
mg/g 
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(Table 11 continued) 
Organism Measured 
Response 
End 
point 
Dose 
(ppb) 
Trend Exposure 
time 
Reference 
Oryzias latipes 
(Medaka) 
Sex Reversal – 
primary germ 
cell number 
and gonad size 
NOEC 1 x 10
-4
  
6 days post 
hatch 
Papoulias et al. 
1999 
Pimephales 
promelas 
(Fathead 
Minnow) 
Development 
of Secondary 
Sex 
Characteristics 
NOEL 5 x 10
-2
  
106 – 150 dph 
 
 
Parrott and 
Blunt 2005 
Pimephales 
promelas 
(Fathead 
Minnow) 
Sexual 
Development
—number of 
normal 
developed 
tubercles 
NOEC 
5 x 10
-4 
and 
1
 
x 10
-3 – 2 
x 10
-3 
Decrease 21 days 
Pawlowski et 
al. 2004 
LOEC 7 x 10
-4
   
Pimephales 
promelas 
(Fathead 
Minnow) 
Number of 
normal 
developed 
tubercles 
NOEC 
1 x 10
-3 
– 
2 x 10
-3 
Decrease 
21 days 
 
Brian et al. 
2007 
Normal 
shape/promine
nce of 
tubercles 
NOEC 5 x 10
-4
 Decrease  
Normal 
shape/promine
nce of 
tubercles/size 
NOEL 5 x 10
-3
 Increase  
Pimephales 
promelas 
(Fathead 
Minnow) 
Sexual 
Development 
– Mean 
number of 
tubercles 
NOEL 3 x 10
-4
  28 days 
Bogers et al. 
2007 LOEL 1 x 10
-3
   
Poecilia 
reticulate 
(Guppy) 
Sperm count 
LOEL 2 Decrease 108 days 
Nielsen and 
Baatrup 2006 
 
1 x 10
-2
 
Significant 
Increase 
 
Tilapia aurea 
(Tilapia) 
Sex reversal 
 
5 x 10
4
 
100% sex 
reversal 
19 days 
Nakamura and 
Takahashi 
1973; 
Papoulias et al. 
1999 
 
Fluoxetine Performance in Animals 
 It is plausible to assume that SSRIs could produce similar pharmacological responses in 
fish as those seen in humans and other mammals (Kreke and Dietrich 2008).  However, due to 
interactions with other neurotransmitters and hormones along with the complexity of the 
serotonergic system, ―the downstream effects of SSRI action on known pharmacological target 
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molecules in fish may differ considerably‖ (Kreke and Dietrich 2008).  Selective Serotonin 
Reuptake Inhibitors may produce effects in fish not seen in humans due to phylogenic 
differences in transduction pathways (i.e. those not present or differently regulated) (Kreke and 
Dietrich 2008). A broad range of effects and the ability for bodily chemicals to neutralize and 
return to normal after increases of serotonin suggests that a traditional dose-response relationship 
may not be expected with chronic exposure (Brooks et al. 2003a). 
Fluoxetine may adversely influence the function of the nervous system and associated 
hormonal systems of organisms possessing serotonin. In addition to operating as a 
neurotransmitter, serotonin functions as a hormone directly impacts the immune system, alters 
appetite, modulates sexual function, and influences the establishment of social hierarchies 
through disruption in sexual behavior and aggressive interactions (Barton et al. 2002; Fent et al. 
2006).  
The pineal hormone melatonin is a derivative of serotonin and is thought to modulate 
aggressive behavior and may be an explanation for submissive behavior of organisms exposed to 
SSRIs (Lee et al. 2004). A study on Oncorhynchus mykiss (rainbow trout) using melatonin, 
tryptophan, and the SSRI citalopram, concluded that it is the 5-HT that is the antiaggressive 
agent in fish.  The melatonin group had no significant effect while the other two group decreased 
aggression and lowered plasma controls (Metcalfe et al. 2001). Derivatives of serotonin can 
affect sensory perception (i.e. visual perception) thus disrupting the circandian system which 
regulates organisms’ measurement and interpretation of day duration.  Animals that rely on 
photoperiodic signals can be affected by this. Slight changes in extracellular 5-HT may alter 
behavior output by modulating other signaling cascades and could result in abnormities in  
circadian rhythmic activities including but not limited to sleep, feeding patterns, hunting, 
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reproductive behavior, core body temperature, brain wave activity, cell regeneration, and 
hormone production (Kreke and Dietrich 2008). 
After four week exposure levels of 100 and 500 ppb FLX, female circulating steroid 
concentrations (E2) increased significantly in Japanese medaka (Weston et al. 2003).  The 
modified circulating steroids confirms unpredicted responses including but not limited to sexual 
dimorphisms in P450 activity and potential sexual dimorphisms in serotonin systems 
(Hernandez-Rauda et al. 1999). In some bivalves and crustaceans induced spawning (Fong 
2001).  The induction of mussel spawning points to interference in serotonergic action.  In 
invertebrates, serotonin may stimulate ecdysteroids, ectysone and juvenile hormone, responsible 
for controlling oogensis and vitellogensis (Nation, 2002).  Serotonin stimulates sex steroid 
syntheses and controls the development of oogenesis, including vitellogensis in fish species 
(Arcand-Hoy and Benson 2001).  Serotonin was indicated to enhance the effects of 
gonadotropin-releasing hormone on gonadotropin release from the pituitary gland (Khan and 
Thomas 1994).  
Problem 
It has been apparent that these pharmaceuticals not only illicit lethality but also abnormal 
behaviors that have a number of possible explanations or in some cases cannot be explained.  
Nontarget organisms can experience similar effects shown in mammalian toxicity tests if they 
possess the necessary target receptors and/or biomolecules present in humans and mammals 
(Fent et al. 2006). Aside from the major mode of action which in most instances are fully 
identified; however because pharmaceuticals have multiple secondary modes of actions, 
nontarget tissues and organs can become disrupted, thus complicating the approach to quantify 
possible end points.    
 
 
54 
Despite receiving attention and necessary action by regulatory agencies like FDA and the 
European Union, there is a lack for substantial procedures regarding impending monitoring of 
drug concentrations in the environment and the palpable adverse effects (Rahman et al. 2007).  
 Published literature is minute when you take into consideration the large amount of 
APIs, metabolites, and other transformation products developed and pumped into the 
environment, sublethal/lethal effects that may have not occurred, the number of potential non-
target organisms (Daughton et al. 1999).   
 When compared to other man-made pollutants (pesticides, household and personal care 
products), pharmaceuticals represent a minute portion of environmental pollutants.  Aquatic 
organisms are exposed to pharmaceuticals through the aforementioned pathways for their entire 
life-cycle thus making them important targets.  However, little is known about effects on these 
organisms. Organisms that are affected on subtoxic levels effects may result in long-term 
changes that may become manifested in succeeding generations of a given species in an 
ecosystem (Halford 2008).  Acute data alone may not be suitable for specifically addressing the 
question of environmental effects and subsequently in the hazard and risk assessment (Fent 
2003).  A major concern is those effects which may be barely noticeable but accumulate over 
time to yield extreme changes which would be masked by time and perhaps not distinguishable 
from natural events.  Even faint variations in routine life development have the capability to 
directly or indirectly affect entire ecosystems through chain reactions originating from 
disturbances in a single population or species.  Upsetting the environmental balance can result in 
unforeseen catastrophes through deteriorations of entire ecosystems.   
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MATERIALS AND METHODS 
Several single species studies using the EPA Acute Static Renewal Test (EPA-821-R-02-
012) (USEPA 2002) were conducted.  Test organisms were exposed to six concentrations of 
Ethinyl estradiol and fluoxetine for 96 hours and a control with four replications each.  A total of 
35 beakers were used for each single species test.  Twenty four beakers housed exposed 
organisms while four beakers housed controlled organisms.  Seven beakers containing the fifth 
replicate of concentrations were void of organisms and used for daily monitoring of water 
parameters.  Daily monitoring of organisms were documented daily to assess time framed dose-
responses for each test organism at each concentration.  The highest test concentrations were 
chosen into order to induce at least 50% lethality (LC50) based on reported studies of similarly 
classified organisms.  After test termination, mortality curves were analyzed to quantify 96 hour 
LC50s, NOECs, LOECs, and Ch.V.s for each of the five standard EPA test organisms exposed to 
ethinyl estradiol and fluoxetine.   Ceriodaphnia dubia (water flea), Daphnia pulex (water flea), 
and Pimephales promelas (fathead minnow), which are freshwater species, and Mysidopsis bahia 
(mysid shrimp) and Menidia beryllina (inland silverside) which are marine species were chosen 
because currently there are no acute toxicity tests incorporating EE2 and FLX induced effects on 
these standard EPA organisms.  The test organisms include simple and complex aquatic species 
both of freshwater and marine habitats, thus encompassing a wide spectrum of test organisms.  
In addition to assessing, comparing, and contrasting mortality, this study extended 
beyond lethality through the observation of sublethal effects which are not required for acute test 
methods.  Abnormalities observed during the test were documented and concentration 
boundaries were established for sublethal effects.   
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Methodology 
Ethinyl estradiol (USP grade) and fluoxetine HCl (98% purity), both obtained from AK 
Scientific, Inc. (Mountain View, California), were used in preparing 6 concentrations with 5 
replicates (1 replicate void of organisms for water quality testing).  Organisms were kept in a 
controlled laboratory environment for 96 hours amid an 18/6 hour light/dark period with a light 
intensity of 50-100 ft/c (REED LM-81LX Light Meter). 
The immature/juvenile organisms were obtained from CK Associates Aquatic 
Toxicology Laboratories (Baton Rouge, Louisiana) on the morning of test initiation and housed 
in the controlled laboratory space for approximately three hours to acclimate to room 
temperature which remained constant at 25 ± 1°C. Ceriodaphnia dubia, Daphnia pulex, 
Pimephales promelas, Mysidopsis bahia, and Menidia beryllina were housed in borosilicate 
beakers arranged in a randomized block order and covered with sleeves of Plexiglas® to prevent 
external contamination. 
Table 12.  Age and number of test organisms deposited into the elected beaker size containing 
the corresponding amount of dosing solution. 
Test 
Organism 
Age 
Number of 
Organisms in 
Container 
Beaker Size 
(mL) 
Amount of Solution 
in Beaker 
(mL) 
Ceriodaphnia dubia < 24 hours 
old 
5 30 15 
Daphnia pulex < 24 hours 
old 
5 30 20 
Pimephales promelas 1 day old 10 400 250 
Mysidopsis bahia 1 day old 10 400 250 
Menidia beryllina 13 days old 10 400 250 
 
Glassware 
Borosilicate glassware was used to prevent any chemicals from changing composition or 
possible leaching into pores of containers which could subsequently affect test results.  Prior to 
test initiation, the glassware was soaked overnight in a bath of NOCHROMIX® and sulfuric 
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acid.  NOCHROMIX® is a patented, white crystalline, inorganic oxidizer packaged in pre-
measured, hermetically sealed pouch.  When mixed with sulfuric acid, it forms a clear, strong 
cleaning solution.  The glassware was then transferred to a deionized (DI) water bath and rinsed 
with DI water to dilute and wash away residual material.  After rinsing with laboratory grade 
acetone, the glassware was rinsed again with DI water.  They were let to air dry on clean white 
contact paper.   
Water Quality 
Forty liters of aerated DI water was used to prepare stock solutions, concentrations, and 
controls.  Because Mysidopsis bahia and Menidia beryllina are marine organisms, salinity had to 
be added to the DI water used for these organisms.  For each 1 liter of DI water, 15 grams of 
Instant Ocean® was added. 
Daily monitoring of water parameters was performed in the fifth replicate of the control 
(aerated DI water) and six concentrations, all void of organisms. Alkalinity (as CaCO3 in ppm) 
and Hardness (ppm) were approximated colormetrically using Hach AquaCheck Dip-and-Read 
Water Quality Test Strips.  Temperature was taken by means of Fisher Scientific Traceable 
Digital Thermometer with stainless steel probe in °C with.  A certificate from ISO 17025 
calibration laboratory was included and accredited by A2LA to confirm accuracy.  The pH meter 
used was ORION Research 230A Digital, Portal pH probe.  Dissolved oxygen was measured 
with OAKTON® DO 300 Waterproof Data Meter.   
Dosing 
Stock solutions were prepared at test initiation and 48 hour test renewal by mixing the 
measured amounts of chemicals with aerated deionized water.   Chemicals were left in 
refrigerator and left to sit on table top for about 1 hour to remove any moisture before weighing.  
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The scale was accurate to 0.000 mg.  The concentrations were prepared by diluting the stock 
solution by 6.5, 12.5, 25, 50, and 100% with room temperature aerated DI water. 
Table 13.  Test concentrations of ethinyl estradiol and fluoxetine after appropriate dilutions were 
made to the measured amount used in the stock solution. 
  
Concentration in μg/L  
(parts per billion) 
Amount 
measured for 
stock 
solution 
(mg) Test Organism Drug 
1 2 3 4 5 
Stock 
6 
Ceriodaphnia 
dubia 
EE2 200 400 900 2000 4000 7000 7.010 
FLX 7 20 30 60 100 200 0.936 
Daphnia 
Pulex 
EE2 300 600 1000 3000 5000 10000 10.361 
FLX 60 100 200 500 900 1000 1.404 
Pimephales 
promelas 
EE2 100 200 400 800 2000 3000 3.202 
FLX 10 20 40 90 200 400 0.353 
Mysidopsis 
Bahia 
EE2 80 200 300 600 1000 2000 2.398 
FLX 20 50 100 200 400 800 0.760 
Menidia 
Beryllina 
EE2 100 200 400 800 2000 3000 3.201 
FLX 50 100 200 400 900 2000 1.716 
 
Transferring organisms 
Test initiation.  Using 10 mL borosilicate large tip opening serological pipettes, 
organisms were randomly distributed 1 at a time to differing concentrations and replicates. 
Test renewal.  Ceriodaphnia dubia and Daphnia pulex were transferred into clean 30 mL 
beakers with the corresponding amount and concentration by using the wide tip pipette.  The test 
solution of Pimephales promelas, Mysidopsis bahia, and Menidia beryllina was removed with 
serological pipettes until about 5 mL remained. The beakers were then refilled with fresh 
solutions to bring the volume back to 250 mL. 
Feeding 
Test organisms were fed daily with feedings 2 hours before test initiation and 2 hours 
before renewal.  The required foods were also obtained from CK Associates which included a 
CEROPHYLL®, a mixture of green unicellular algae and yeast, and Trout Chow for water fleas 
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and Artemia nauplii less than 24 hours old for other organisms. Before feeding regimes, Artemia 
nauplii were rinsed with DI water to remove the saline solution.  Excess Artemia was removed 
before feeding the test organisms the next day.  The excess food was gathered by pipetting the 
clumps of remaining food while leaving as much solution as possible. 
Table 14.  Amount of standard food given to test organisms.  Organisms were fed at least two 
hours before test initiation and twice a day on subsequent days until test termination. 
Test Organism   Food Amount of Food 
Ceriodaphnia dubia CEROPHYLL® and Trout 
Chow 
0.1 mL each 
Daphnia pulex CEROPHYLL® and Trout 
Chow 
0.1 mL each 
Pimephales promelas Artemia nauplii  0.2 mL 
Mysidopsis bahia Artemia nauplii  0.2 mL (100 Mysid per 
organism) 
Menidia beryllina Artemia nauplii  0.2 mL 
 
Endpoints 
Observations were made daily beginning with control organisms.   The entire beaker was 
carefully moved to a light table and all observations, lethal and sublethal, were recorded at the 
time of observation.   
Lethal.  Deceased organisms were usually present at the bottom of the beaker and were 
removed with large tip opening pipettes.  Organisms floating listlessly were gently probed with 
large tip opening pipettes to confirm survival. The number of surviving organisms were recorded 
daily in each container and averaged within concentrations at test termination.  To ensure that 
toxicity of the drug not cannibalism was causing mortalities, the number of dead organisms 
removed daily was also recorded.   
Sublethal.  During observations, any recorded abnormalities were compared to the 
control and surrounding concentrations to confirm irregularities.  After test termination changes 
in behavior and/or abnormalities were summarized, compared, and contrasted throughout 
concentrations and organisms.   
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Statistical Analysis 
Daily observations of survival were plotted on Dose Response Plot and analyzed using 
ToxCalc5.  The mortality percentages presented in the successive chapters employ the 
untransformed data which are based on averages of the four replicates. The average survivorship 
was transformed to Arcsine Square Roots to establish which concentrations caused survivorship 
statistically different from the control. The purpose of transforming the data was to set 
survivorship of the control equal to 100%.  Based on Shapiro Wilk’s Test with a variance of 0.01 
this transformed data was used to establish normal or non-normal distribution.  If non-normal 
distribution of transformed data was found or no equality of variance could be determined, the 
hypothesis test used was Steel’s Many One Rank Test with a 0.05 variance.  This hypothesis test 
determined the no observable effect concentration (NOEC), lowest observable effect 
concentration (LOEC), and the chronic value (Ch.V.) based on survivorship. The ChV. is the 
determined from a ratio of the NOEC and LOEC and is presumed ―safe.‖  It should be lower 
than the EC50. Based on the definition of the chronic value the EC50 is usually slightly higher 
than Ch.V. 
To establish the dose-response curve, the Maximum Likelihood-Probit Method was used 
to determine the Effective Concentration (ECx) with upper and lower 95% fiducial limits when 
applicable.  The fiducial limits are the boundaries within which a parameter is considered to be 
located.  In this case the EC represents the effective concentration of the desired percent 
mortality (x).  In a normal dose-response curve, the y-axis is usually the mortality response and 
the x-axis is the dose of the drug.  As the dose increases the effect should increase.  Hormetic 
responses show an opposite effect in small doses compared to large doses.  The lower doses 
stimulate more lethal effects than the higher doses.  The result is a J-shaped or an Inverted U-
shaped dose response curve.     
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RESULTS 
Lethal Effects 
Daily observations of survival were documented to assess the time framed dose-
responses for each test organism at each concentration.  The dose-response curve was used to 
quantify the effective concentration at which an average of 50% of test organisms encountered 
lethal effects (EC50 or LC50). The upper and lower 95% fiducial limits were the applicable 
boundaries within which the ECx was considered to be located.   The y-axis of the dose-response 
curve was the response, the percent mortality, caused by the dose of the drug which is 
represented in the x-axis. A normal dose-response curve resembles an S-shape; this implies that 
as the dose or concentration increases, so should the response.  The opposite effect in which 
lethal effects were induced by lower concentrations resulted in a J-shaped or an Inverted U-
shaped dose response curve and categorized as a hormetic response.  
After test termination, lethal effects to ethinyl estradiol (Table 15) and fluoxetine (Table 
16) were documented as percent mortality which incorporates the average untransformed 
lethality of test organisms caused after 96 hours of exposure.  Derived from the transformed data 
were the statistically significant concentrations, the NOECs, and the LOECs.  The chronic value 
was statistically elected from the NOEC/LOEC ratio.  By definition, this concentration is not 
considered to be harmful thus it should be lower than the EC50. 
Lethal Effects of Ethinyl Estradiol to Ceriodaphnia dubia   
The normal dose-response of Ceriodaphnia dubia exposed to 200 – 7000 ppb of ethinyl 
estradiol yielded an EC50 of 400 ppb which had 95% fiducial limits of 400 and 300 ppb (Figure 
1).  Based on the 20 organisms allotted for each of the concentrations, the average mortality was 
compared to the control (0% mortality).  The only concentration not statistically significant when 
compared to the control was the NOEC, 200 ppb, which only had 20% mortality.  Statistically 
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significant figures included the LOEC, 400 ppb, which had 60% mortality, and 900, 2000, 4000, 
and 7000 ppb all bared 100% mortality (Table 15). The chronic value, 300 ppb, was only slightly 
lower than the EC50.  
 
 Figure 1. The Ceriodaphnia dubia dose-response curve and 95% fiducal limits derived from the 
average mortality of four replications caused by 96 hours of exposure to 200 – 7000 ppb of 
Ethinyl estradiol.  The EC50 of 400 ppb had 95% fiducial limits of 400 and 300 ppb when 
compared to 0 because no mortality was observed in the control. 
 
Lethal Effects of Ethinyl Estradiol to Daphnia pulex  
The dose-response of Daphnia pulex after 96 hours of exposure to ethinyl estradiol 
concentrations of 300 -10000 ppb, the EC50, 6000 ppb, with limits of 5000 and 8000 ppb 
resulted from the control of 0.1 (Figure 2).  Due to 10% mortality in the control the statistically 
insignificant concentrations included the NOEC, 3000 ppb, (20% mortality) as well as the lesser 
concentrations which exhibited a hormetic curve: 300 (25%), 600 (5%), and 1000 ppb (30%).  
Significantly different concentrations included the LOEC, 5000 ppb, which caused 40% 
mortality and 10000 ppb triggered 95% mortality (Table 15).  The Ch.V., 4000 ppb, was based 
on a ratio of the NOEC and the LOEC. 
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Figure 2. The Daphnia pulex dose-response curve and 95% fiducal limits derived from the 
average mortality of four replications caused by 96 hours of exposure to 300 -10000 ppb of 
ethinyl estradiol. The EC50 of 6000 ppb had 95% fiducial limits of 5000 and 8000 ppb when 
compared to 0.1 because 10% mortality was observed in the control. 
 
Lethal Effects of Ethinyl Estradiol to Pimephales promelas  
 The normal dose-response of Pimephales promelas exposed to 100 –3000 ppb of EE2 
resulting in the anticipated EC50 of 11000 ppb.  No fiducial limits were determined; however, a 
significant heterogeneity was detected at p = 3.87 x 10
-4
 (Figure 3). The dose response plot 
exhibited a bell curve with disruption in the plot at the following insignificant values compared 
to the control (0% mortality): 100 (5%), 200 (3%), 400 (0%), and 800 ppb (3%).   The NOEC, 
2000 ppb, ended with only 8% mortality. The only significantly different concentration was the 
LOEC, 3000 ppb, which was highest concentration. Because this level only yielded 40% 
mortality (Table 15), the resulting Ch.V. was 2000 ppb. 
 
Lethal Effects of Ethinyl Estradiol to Mysidopsis bahia   
The normal dose-response of Mysidopsis bahia exposed to 80 – 2000 ppb had an EC50 
was 400 ppb with a large range of fiducial limits, 40 - 2000 ppb with control 0.075 (Figure 4).   
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Figure 3. The Pimephales promelas dose-response curve derived from the average mortality of 
four replications caused by 96 hours of exposure to 100 –3000 ppb of ethinyl estradiol.  The 
EC50 of 11000 ppb had no fiducial limits when compared 0 because no mortality was observed 
in the control.  Given that a non-normal response was created a significant heterogeneity was 
detected at p = 3.87 x 10
-4
. 
 
Figure 4. The Mysidopsis bahia dose-response curve and and 95% fiducal limits derived from 
the average mortality of four replications caused by 96 hours of exposure to 80 – 2000 ppb of 
ethinyl estradiol.  The EC50 of 400 ppb had 95% fiducial limits of 40 - 2000 ppb when 
compared to 0.075 because 7.5% mortality was observed in the control. 
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Mortality remained fairly constant from control – 300 ppb (5-7% mortality); however, organisms 
exposed to 80 ppb faced less mortality than control.  The NOEC, 300 ppb, and 200 ppb 
experienced identical changes in mortality of about 13%. At the LOEC, 600 ppb, mortality 
plummeted to about 68% assigning a Ch.V. of 400 ppb.    Significantly different concentrations 
of 1000 and 2000 ppb suffered about 95-100% mortality respectively (Table 15).   
Lethal Effects of Ethinyl Estradiol to Menidia beryllina   
The normal dose-response of Menidia beryllina exposed to 100 – 3000 ppb caused the 
EC50, 2000 ppb, with fiducial limits of 1000 and 2000 ppb, which was compared to 0.025 due to 
mortality in the control (Figure 5).  A slight hormetic effect was observed in concentrations less 
than 400 ppb rendering them insignificant.  The control and 200 ppb organisms experienced 
about 2.5% mortality while 100 ppb had 5% and 400 ppb had 0% mortality.  Additionally the 
NOEC, 800 ppb, was also insignificant affecting about 13%.   
 
Figure 5.  The Menidia beryllina dose-response curve and 95% fiducal limits derived from the 
average mortality of four replications caused by 96 hours of exposure to 100 – 3000 ppb of 
ethinyl estradiol. The EC50 of 2000 ppb had 95% fiducial limits of 1000 and 2000 ppb, when 
compared to 0.025 because 2.5%.mortality was observed the control. 
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The higher concentrations including the LOEC, 2000, (about 43%) and 3000 ppb (100%) were 
significantly different than the control (Table 15).  A Ch.V. of 1000 ppb was prompted. 
Table 15.  Untransformed data presented as the average percent mortality caused after 96 hours 
of exposure to ethinyl estradiol including the statistically derived concentrations, the NOEC, and 
the LOEC associated with each single species test. 
Ethinyl estradiol Concentration vs. Mortality 
C. dubia D. pulex P. promelas M. bahia M. beryllina 
Dose 
(ppb) 
Mortality 
(%) 
Dose 
(ppb) 
Mortality 
(%) 
Dose 
(ppb) 
Mortality 
(%) 
Dose 
(ppb) 
Mortality 
(%) 
Dose 
(ppb) 
Mortality 
(%) 
Control 
0 
0 
Control 
0 
10 
Control 
0 
0 
Control 
0 
6.67 
Control 
0 
2.5 
200 
NOEC 
20 300 25 100 5 80 5.28 100 5 
*400 
LOEC 
60 600 5 200 2.5 2000 5 200 2.5 
*900 100 1000 30 400 0 
300 
NOEC 
8.06 400 0 
*2000 100 
3000 
NOEC 
20 800 2.5 
*600 
LOEC 
53.17 
800 
NOEC 
12.5 
*4000 100 
*5000 
LOEC 
40 
2000 
NOEC 
7.5 *1000 93.75 
*2000 
LOEC 
42.5 
*7000 100 *10000 95 
*3000 
LOEC 
40 *2000 100 *3000 100 
*Statistically significant concentrations were derived using TOXCALC 5 by transforming the 
average survivorship to Arcsine Square Roots. Based on the Shapiro Wilk’s Test with a variance 
of 0.01 this transformed data was used to determine statistically significant concentrations.  
NOECs and LOECs were established using Steel’s Many One Rank Test with a 0.05 variance. 
 
Lethal Effects of Fluoxetine to Ceriodaphnia dubia 
 
The non-normal dose-response of Ceriodaphnia dubia exposed to 7 – 200 ppb contained 
no fiducial limits to the assigned EC50 of 5 ppb, but a significant heterogeneity was detected at 
p = 2.68E-10. Control was 0.1 due to mortality in the control (Figure 6).  Concentrations not 
significant from the control (10%) included 7 ppb which had 25% mortality and the NOEC, 100 
ppb, (60%).  Median concentrations of 20, 30, and 60 ppb triggered 100% mortality at the end of 
96 hours and made them significantly different than the control.  The highest concentration was 
deemed the LOEC, 200 ppb, which stimulated 95% mortality.  Because of the decrease in 
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mortality at the NOEC, the LOEC was not the first significant figure.  The Ch.V. of 200 ppb was 
based on this effect (Table 16). 
 
 
Figure 6. Ceriodaphnia dubia dose-response curve derived from the average mortality of four 
replications caused by 96 hours of exposure to 7 – 200 ppb of fluoxetine.  The EC50 of 5 ppb 
had no 95% fiducial limits when compared to 0.1 because 10% mortality was observed the 
control.  Given that a non-normal response was created a significant heterogeneity was detected 
at p = 2.68 x 10
-10
. 
 
 
Lethal Effects of Fluoxetine to Daphnia pulex 
 
The normal dose-response of Daphnia pulex exposed to 60 – 1000 ppb The EC50, 200 
ppb, with upper and lower 95% fiducial limits of 300 and 100 ppb were compared to a control of 
0.1 (Figure 7). The control and 100 ppb retained 10% mortality while the median concentration, 
60 ppb, gained 15% mortality.  These concentrations along with the NOEC, 200 ppb, (80%) 
remained insignificant.  The LOEC, 500 ppb, which lead to 90% mortality, and 900 and 1000 
ppb both with 100% mortality were all significantly different than the control (Table 16).  The 
Ch.V. was determined to be 300 ppb. 
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Figure 7.  The Daphnia pulex dose-response curve and 95% fiducal limits derived from the 
average mortality of four replications caused by 96 hours of exposure to 60 – 1000 ppb of 
fluoxetine.  The EC50 of 200 ppb had 95% fiducial limits of 300 and 100 ppb when compared to 
0.1 because 10% mortality was observed the control. 
 
Lethal Effects of Fluoxetine to Pimephales promelas 
 
The dose-response of Pimephales promelas Exposed to 10 – 400 ppb The EC50 was 200 ppb 
with an upper limit of 200 and a lower limit of 200 ppb (Figure 8).  The control together with the 
lesser concentrations of 10, 20, and 40 ppb, all yielded 0% mortality which scored them as 
insignificant.  The NOEC, 90 ppb, concluded in only 3% mortality.  The two concentrations 
statistically different than the control included the LOEC, 200 ppb, which caused a 40% change 
and 400 ppb which affected 100% of the organisms (Table 16).  The Ch.V. transpired as 100 
ppb. 
Lethal Effects of Fluoxetine to Mysidopsis bahia 
 
The non-normal dose-response of Menidia beryllina exposed to 20 – 800 ppb EC50 was 
500 ppb with no limits available established a significant heterogeneity of p = 2.96 x 10
-3
 (Figure 
9).   
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Figure 8. The Pimephales promelas dose-response curve and 95% fiducal limits derived from the 
average mortality of four replications caused by 96 hours of exposure to 10 – 400 ppb of 
fluoxetine.  The EC50 of 200 ppb had 95% fiducial limits of about 200 ppb when compared to 0 
because no mortality was observed the control. 
 
 
Figure 9.  The Mysidopsis bahia dose-response curve derived from the average mortality of four 
replications caused by 96 hours of exposure to 20 – 800 ppb of fluoxetine.  The EC50 of 500 ppb 
had no 95% fiducial limits when compared 0 because no mortality was observed in the control. 
Given that a non-normal response was created a significant heterogeneity was detected at 
 p = 2.96 x 10
-3
. 
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There was an immense decrease in mortality at 20 ppb (40%) when compared to the next highest 
concentration of 50 ppb, the NOEC, (13%).  This NOEC was the only concentration not 
significantly different from control (0% mortality).  A hormetic effect occurred between 
concentrations 100, the LOEC, and 400 ppb. Mortality decreased from 47.5% - 35%.  Increased 
mortality was observed at the next highest concentration, 800 ppb (62.5%).  The Ch.V. was 70 
ppb because the NOEC exhibited a lower mortality than lesser concentrations (Table 16).     
Lethal Effects of Fluoxetine to Menidia beryllina 
The dose-response of Menidia beryllina exposed to 50 – 2000 ppb EC50, 500 ppb, with 
upper and lower limits of 500 and 600 ppb.  The control for comparison was 0.025 (Figure 10).   
 
Figure 10. The Menidia beryllina dose-response curve and 95% fiducal limits derived from the 
average mortality of four replications caused by 96 hours of exposure to 50 – 2000 ppb of 
fluoxetine.  The EC50 of 500 ppb had 95% fiducial limits of 500 and 600 ppb when compared to 
0.025 because 2.5% mortality was observed the control. 
 
Concentrations not significantly different than the control (about 3%) included  50 ppb (about 
13%) and the NOEC, 200 ppb, (20%); however, 100 ppb also had 20% mortality but was 
considered significant. Remaining concentrations were also regarded as significant.  Compared 
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to the LOEC, 400 ppb, which caused 35% mortality, exposure to 900 ppb caused a severe incline 
in mortality (about 93%) along the highest concentration of 2000 ppb (100%) (Table 16). The 
Ch.V. of 300 ppb was less than EC50, 500 ppb. 
 
Table 16.  Untransformed data presented as the average percent mortality caused after 96 hours 
of exposure to fluoxetine including the statistically derived concentrations, the NOEC, and the 
LOEC associated with each single species test. 
Fluoxetine Concentration vs. Mortality 
C. dubia D. pulex P. promelas M. bahia M. beryllina 
Dose 
(ppb) 
Mortality 
(%) 
Dose 
(ppb) 
Mortality 
(%) 
Dose 
(ppb) 
Mortality 
(%) 
Dose 
(ppb) 
Mortality 
(%) 
Dose 
(ppb) 
Mortality 
(%) 
Control 
0 
10 
Control 
0 
10 
Control 
0 
0 
Control 
0 
0 
Control 
0 
2.5 
7 25 60 15 10 0 *20 40 50 12.5 
*20 100 100 10 20 0 
50  
NOEC 
12.5 *100 20 
*30 100 
200 
NOEC 
80 40 0 
*100 
LOEC 
47.5 
200 
NOEC 
20 
*60 100 
*500 
LOEC 
90 
90   
NOEC 
2.5 *200 45 
*400 
LOEC 
35 
100       
NOEC 
60 *900 100 
*200 
LOEC 
40 *400 35 *900 92.5 
*200 
LOEC 
95 *1000 100 *400 100 *800 62.5 *2000 100 
*Statistically significant concentrations were derived using TOXCALC 5 by transforming the 
average survivorship to Arcsine Square Roots. Based on the Shapiro Wilk’s Test with a variance 
of 0.01 this transformed data was used to determine statistically significant concentrations.  
NOECs and LOECs were established using Steel’s Many One Rank Test with a 0.05 variance. 
 
Sublethal Effects  
Because the environmental amounts are below those to stimulate mortality these results 
of this study extend beyond lethality through the observation of sublethal effects which are not 
required for acute test methods.  In addition to high toxicity potential these two pharmaceuticals 
are extremely potent in controlling hormonal, serotonergic, and dopaminergic systems in 
mammals/humans which could interfere with key biological functions including but not limited 
to fecundity, growth and development, and behavior in nontarget organisms.  Organisms are 
exposed for entire life cycles in environmental settings.  In the current study juvenile organisms 
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were exposed during an important life stage of growth and development.  Any changes could be 
important to note because they were occurring within 96 hours.  
Sublethal Effects of Ethinyl Estradiol 
Ceriodaphnia dubia decreased activity as time and concentration increased. At the end of 
96 hours the C. dubia exposed to 200 ppb, the NOEC, had 1 larval offspring in each container; 
additionally, deceased organisms observed in microscopic photos had larvae in the brood 
chamber.  The number of offspring ranged from 1-7 for organisms exposed to 400 ppb, the 
LOEC.  
Daphnia pulex exposed to 300 ppb became lethargic and lifeless after 72 hours exposure.  
Those granted 300 and 1000 ppb for 24 hours began swimming around the parameter of the 
beaker.  At 72 hours in 5000 ppb, organisms crashed into the sides of the beakers and attempted 
escape.  Eggs were first observed on the tails of D. pulex at 24 hours in 10000 ppb. At 72 hours 
in 1000 ppb. D. pulex appeared to have eggs in the brood chamber and looked much larger by 
comparison.  Offspring were observed in 600 and 3000 ppb. At test termination, ephippia were 
present at the base of the beaker in concentrations greater than 3000 ppb.  Ephippia are fertilized 
resting eggs encased in a tough covering to withstand extreme conditions.  These ―winter eggs‖ 
are released by the female under times of stress and rest at the bottom of a water body until 
favorable conditions return.  At 72 hours, organisms in 300 ppb were missing.  In concentrations 
300 and 1000 ppb at the end of 96 hours, dead daphnia appeared to have been eaten by survivors.   
Prior to test renewal in 10000 ppb, the water appeared cloudy possibly from algae dying. 
Pimephales promelas exposed to EE2 decreased general activity as time and 
concentration increased.  Most of the minnows in 400 – 3000 ppb became extremely lethargic as 
time increased.  However, during the first 24 hours, organisms in 800 ppb became frantic.  Few 
swim abnormalities were observed in 400 and 2000 ppb; the organisms began swimming 
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inconsistently throughout the water column and jumpy and became disoriented for the entire test.  
At concentrations above 800 ppb the organisms remained quite drab in color. During the first 
few days of the test, roughly 2-5 minnows yielded aggressive and probing actions at 800 and 
2000 ppb.  Those administered 800 ppb ceased aggressive activity as time increased; on the other 
hand organisms in 2000 ppb continued this behavior for duration of the test. In 100 and 200 ppb 
deceased minnows appeared damaged and mutilated by the remainders.  The underbelly of a 
minnow in 3000 ppb appeared injured. Interestingly, this concentration triggered an enormous 
engorgement of swim bladders.  Upon microscopic investigation is was shown that swim bladder 
size increased in a dose dependent manner.   
 Mysidopsis bahia displayed aggressive behaviors in 1000 ppb at 24 hours and 80 ppb at 
72 hours. Hostility was delayed in lesser concentrations but in higher concentrations this activity 
decreased with time.  In concentrations 300 ppb and below, cannibalism decreased as 
concentrations increased. Cannibalism ceased after 24 hours in concentrations above 600 ppb. 
Feeding decreased at concentrations 1000-2000 ppb; however, the artemia, were alive and very 
active.  The food source appeared to much more active in concentration 2000 ppb but were 
motionless after one day. Mysid subjected to 200 ppb were noticeably larger and darker after 72 
hours observation.  Similarly, denser coloration was observed in all unexposed organisms and 
sporadically throughout lesser concentrations; however, those subjected to EE2 were more 
massive.  
Menidia beryllina became motionless after 72 hours of exposure which became more 
appreciated in elevated concentrations. In 400 ppb fish exhibited extremely restless behavior that 
decreased with time. Swim abnormalities of organisms in 2000 ppb were observed at 48 hours in 
which they began flipping backwards. Throughout the test the number of organisms that 
experienced tremors in 2000 and 3000 ppb correlated with lethality.  For example, in the highest 
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test concentration, the organisms began seizing at 24 hours and the next day suffered 100% 
mortality. Accelerated maturation was observed in those exposed to 100-200 ppb by evidence of 
pigmentation at the head.  One organism in 2000 ppb had a yellow body with a clear tail which 
supposedly occurs when they reach maturity.  Engorged abdomens developed at 48 hours in 200-
400 ppb.   
Sublethal Effects of Fluoxetine  
Ceriodaphnia dubia began lifelessly floating on edge of the beaker at 20 – 200 ppb. For 
the entirety of the test, organisms in 7 ppb were very active and anxious; this concentration 
caused organisms to increase in size compared to the control or elevated concentrations. 
Daphnia pulex in 200 ppb at became immobilized after 48 hours. At concentrations 
above 500 ppb, the majority of organisms remained lethargic throughout the entirety of the test.  
Abnormal swim behaviors were observed at 48 hours in 60 ppb in which the daphnia exhibited 
extremely jerky swimming motions. Throughout the test, organisms in this concentration 
appeared to be combating and/or mating; however, neither eggs nor offspring were detected.  In 
100 ppb at test termination, organisms appeared to be rotating backwards and swimming in 
circles around beaker.  Daphnia appeared to increase size in 900 and 1000 ppb.  In the lesser 
concentrations, abdomens were distended.   
Pimephales promelas were floating listlessly on the surface of the water table; 
nonresponsiveness became more appreciated as concentration and time increased.   In 20 - 40 
ppb minnows displayed stationary vertical positioning. A small number of minnows in 10 – 90 
ppb appeared disoriented; however this activity decreased as time and concentration increased. 
Restless behavior decreased as concentration and time increased.  At test termination fathead 
minnows in 90 – 200 ppb became aggressive by probing the inactive organisms at the surface. 
Interestingly enough, organisms in these concentrations had crooked spines and began swimming 
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in corkscrew motion.  The spine curvature was confirmed by microscopic observation; 
additionally confirmed were the larger and lighter swim bladders of exposed organisms.  
Mysidopsis bahia exposed to FLX displayed very little activity; however, those in 190 
ppb were larger and more active than mysid in 100, 400, and 800 ppb.  These later 
concentrations triggered abnormal behaviors.  At 24 hours organisms in 800 ppb executed 
tumbling behaviors.  Those in 100 ppb exhibited this same behavior at 48 hours but were 
inflicted with crooked tails.  Organisms exposed to concentrations above 200 ppb, exhibited 
decreased feeding and pigmentation. During the first 24 hours, cannibalism was observed in all 
concentrations of FLX except 50 ppb, the NOEC.  As concentrations increased, casualties due to 
cannibalism decreased in response to the decrease in antagonistic behavior  
Menidia beryllina exposed to lower concentrations were hovering at the surface showing 
very little activity.  During first 24 hours, organisms in higher concentrations exhibited fits of 
agitation.   After test renewal, immobilization increased with time and concentration; at test 
termination all exposed organisms were lethargic.  In addition, prior to 48 hour test renewal, 
catatonic behavior and vertical positioning was more prominent in all organisms as time and 
concentration increased.  Exposure to 900 and 2000 ppb convulsing and seizing; CNS toxicity 
correlated with fatality. Few fish suffered inflamed abdomens.  
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DISCUSSION 
Because the basis of the study rested on the hypothesis that similarly classified organisms 
would exhibit similar responses in mortality, the organisms’ responses were compared and 
contrasted against different levels:  dose-response plots, the percent mortality detected at a 
median concentration, the lowest concentration that induced 100% mortality, the median 
effective concentration based on lethality (EC50 or LC50), and the chronic value derived from a 
ratio of the no observable concentrations and the lowest observable effect concentrations based 
on mortality. After test termination, mortality curves were analyzed to quantify 96 hour LC50s, 
NOECs, LOECs, and Ch.V.s for each of exposed to ethinyl estradiol and fluoxetine. 
Lethal Effects Based on Dose-Response Plot  
To compare and contrast the dose induced mortality, the average untransformed percent 
mortality were plotted against the test concentration with the NOECs and LOECs identified in 
ethinyl estradiol (Figure 11) and fluoxetine (Figure 13). A normal response should correlate with 
the dose and form a straight line.  This was observed in dose-response plots of C. dubia exposed 
to ethinyl estradiol (Figure 11) and in D. pulex, P. promelas, and M. beryllina exposed to 
fluoxetine (Figure 13).  
A hormetic response or a disruption in the linear dose-response correspondence was 
observed in D. pulex, P. promelas, M. bahia, and M. beryllina exposed to EE2 (Figure 11) and in 
C. dubia and M. bahia exposed to FLX (Figure 13). 
Dose-response plot effects of ethinyl estradiol.  C. dubia exhibited a normal dose 
response with concentrations above 900 ppb exhibiting 100% mortality. A disruption in the dose 
response plot for D. pulex showed a decrease in mortality in concentrations 600 and 3000 ppb. P. 
promelas, M. bahia, M. beryllina exhibited hormetic response.  D. pulex exhibited a similar 
curve but the disruption in the curve is different.   A significant decrease in mortality from the 
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NOEC to the LOEC was observed in C. dubia and M. bahia producing similar EC50 and chronic 
values around 300 - 400 ppb.  At 3000 ppb M. beryllina had 100% mortality while P. promelas 
had only 40% mortality making it very resilient.  Interestingly at the lesser concentrations, 100 - 
800 ppb both fish exhibited identical hormetic changes in mortality (Figure 11). 
 
Figure 11. The observed percent mortality and the analyzed NOEC and LOEC determined at test 
termination for all test organisms exposed to test concentrations of ethinyl estradiol.  
 
Dose-response plot effects of fluoxetine.  In concentrations 20 – 200 ppb C. dubia 
exhibited a hormetic effect at 48 hours and produced about 100% mortality at test termination.  
A disruption in the dose-response curve in 100 ppb (about 60%) could explain why the chronic 
value is higher than EC50.  D. pulex had a normal dose response curve with the NOEC of 200 
ppb manifesting 80% mortality.  P. promelas had little or no mortality from 0 - 90 ppb and 
exhibited a normal response not including the drastic increase in mortality (3 – 100%) which 
occurred in 90 – 400 ppb.  M. bahia exhibited a slight hormetic change at 100 – 400 ppb (47.5 – 
35%) and reduction in mortality at 50 ppb (NOEC, the only non significant concentration) 
rendering the second significant concentration as the LOEC.  M. beryllina depicted a normal 
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dose response curve with very little change between first three concentrations (50, 100, 200 ppb) 
with a dire variation in mortality after LOEC of 400.  Aside from a slight hormetic change, D. 
pulex and M. beryllina exhibited normal dose response curves.  P. promelas demonstrated this 
normalcy apart from the radical increase in mortality (3 – 100%) from 800 – 3000 ppb (Figure 
12). 
 
Figure 12. The observed percent mortality and the analyzed NOEC and LOEC determined at test 
termination for all test organisms exposed to test concentrations of fluoxetine. 
 
 
Lethal effects based on Median Concentrations and Concentrations Causing Complete 
Mortality  
 
The effects on mortality were projected to be comparable to similarly cataloged 
organisms.  The concentrations needed to induce mortality were expected to be smaller in 
crustaceans Ceriodaphnia dubia (water flea), Daphnia pulex (water flea), and Mysidopsis bahia 
(mysid shrimp) because they are simpler organisms with shorter life cycles, making them more 
susceptible and vulnerable to the toxicants.  Because fish are more complex organisms with more 
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intricate bodily functions and longer life cycles the Pimephales promelas (fathead minnow) and 
Menidia beryllina (inland silverside) were expected to be more resilient to these drugs.   
 
Figure 13.  A comparison of the percent mortality in all species of test organisms caused after 96 
hours of exposure to the median concentrations 2000 ppb of ethinyl estradiol and 100 ppb of 
fluoxetine. 
 
Median concentrations of ethinyl estradiol.  Based on an EE2 concentration of 2000 
ppb, P. promelas had 8% mortality, D. pulex (30-20%), M. beryllina (42.5%), M. bahia (95-
100%) and C. dubia (100%). 
Median concentrations of fluoxetine.  At a concentration of 100 ppb FLX mortalities 
were recorded as D. pulex (10%), P. promelas (3-40%), M. beryllina (20%), M. bahia (47.5 – 
45%), and C. dubia (60%).   
Complete mortality in ethinyl estradiol.  The lowest concentrations of EE2 causing 
100% mortality were as follows:  C. dubia (900 ppb), M. bahia (2000 ppb), M. beryllina (3000 
ppb), P. promelas (8000 ppb), and D. pulex (10000 ppb).  
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Complete mortality in fluoxetine.  The lowest concentration causing 100% were as 
follows: C. dubia (20 ppb), P. promelas (400 ppb), D. pulex (900 ppb), M. bahia (1000 ppb), and 
M. beryllina (2000 ppb). 
 
Figure 14.  A comparison of the lowest concentrations of ethinyl estradiol and fluoxetine 
producing 100% mortality in all species of test organisms.  
 
Median Effective Concentrations Causing Lethality  
The lethal concentrations (LC50s) were expected to be smaller in the crustaceans than in 
the fish.  The highest test concentrations were chosen into order to induce at least 50% lethality 
(LC50) based on literature review of similarly classified organisms (EE2, Table 1; FLX, Table 
5).  Quantified 96 hour LC50s were established for the five test organisms and were compared 
against literature review.   
Ethinyl estradiol EC50s The most sensitive species based on EC50:  C. dubia (400 ppb) 
> M. bahia (600 ppb) > M. beryllina (2000 ppb) > D. pulex (6000 ppb) > P. promelas (10000 
ppb). 
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Similarly classified organisms – crustaceans The three crustaceans produced the 
following 96 hour LC50s after exposure to EE2: Ceriodaphnia dubia (water flea) (400 ppb) > 
Mysidopsis bahia (mysid shrimp) (600 ppb) > Daphnia pulex (water flea) (6000 ppb). 
Compared to the similarly classified test organisms, the Nitocra spinipes (harpacticoid 
copepod), a crustacean whose habitat ranges from fresh water to hypersaline conditions, 
displayed an increase in mortality yielding a 96 hour LC50 of 500 ppb (Breitholtz and Bengtsson 
2001) which was between the quantified LC50s of the two crustaceans, C. dubia (400 ppb) and 
M. bahia (600 ppb), while being significantly lower than the D. pulex.   
The marine shrimp, Neomysis integer (opossum shrimp) showed an increase in mortality 
at 1000 ppb (Verslycke et al. 2004).  The M. bahia is also a marine shrimp but yielded a much 
lower LC50 (600 ppb).  
Watts et al. (2001) showed that the Gammarus pulex (scud) displayed an increase in 
mortality at 2000 ppb.  This freshwater shrimp exhibited an LC50 between that of the M. bahia 
(600 ppb) and the D. pulex (6000 ppb).  Interestingly this freshwater shrimp had a 96-hour LC50 
identical the marine fish, the M. beryllina (2000 ppb). 
Similarly classified organisms – fish.  The two fish species produced the following 96 
hour LC50s after exposure to EE2:  Menidia beryllina (inland silverside) (2000 ppb) > 
Pimephales promelas (fathead minnow) (10000 ppb). 
Versonnen et al. (2003) showed that Danio rerio (zebrafish), a tropical freshwater fish 
belonging to the minnow family, caused an LC50 of 2000 ppb. This 96 hour LC50 is identical to 
the marine fish M. beryllina (2000 ppb) but much lower than the freshwater minnow (10000 
ppb).  
Fluoxetine EC50s.  The most sensitive species based on EC50: C. dubia (5 ppb) > P. 
promelas (200 ppb) > D. pulex (200 ppb) > M. bahia (500 ppb) > M. beryllina (500 ppb). 
 
 
82 
The hypothesis was that similarly classified organisms would have close to the same LC50s. 
Similarly classified organisms – crustaceans.  The three crustaceans produced the 
following 96 hour LC50s after exposure to FLX:  Ceriodaphnia dubia (water flea) (5 ppb) > 
Daphnia pulex (water flea) (200 ppb) > Mysidopsis bahia (mysid shrimp) (500 ppb).  
 Brooks et al. (2003b) found that Ceriodaphnia dubia produced an LC50 of 300 ppb.  
This concentration is close to the other species of water flea, the D. pulex (200 ppb) and the 
freshwater fish the P. promelas (200 ppb).  While still close to the other crustacean, M. bahia 
(500 ppb), the exact same species was much lower than the literature review due to the observed 
hormetic effects. 
Brooks et al. (2003b) also documented the LC50 in another species of water flea, 
Daphnia magna, as 900 ppb.  This concentration was much higher than any of the determined 
LC50s of the test species used in the current study.  
Similarly classified organisms – fish.  The two fish species produced the following 96 
hour LC50s after exposure to FLX:  Pimephales promelas (fathead minnow) (200 ppb) > 
Menidia beryllina (inland silverside) (500 ppb). 
Brooks et al. (2003b) documented the LC50 of Pimephales promelas (fathead minnow) 
as 800 ppb.  In the current study, all test organisms had 96 hour EC50s much lower than this 
concentration. The concentration 400 ppb caused 100% mortality in P. promelas.  According to 
the raw data, M. beryllina experienced 35% mortality at 400 ppb which increased to about 93% 
at 900 ppb. Interestingly, at 800 ppb the crustacean, M. bahia suffered around 63% mortality. 
 Winder et al. (2009) found that Cyprinodon variegatus (sheepshead minnow) a 
marine/brackish water fish only caused 47% mortality in 2000 ppb.  In the current study, the 
highest LC50 was 500 ppb in the M. beryllina (inland silverside) with a documented 100% 
mortality observed at 2000 ppb.  
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The fish species Oryzias latipes (Japanese medaka) had a 96 hour LC50 of 2000 ppb (Eli 
Lilly and Company 2005).  The highest concentration used in the current study of M. beryllina 
was 2000 ppb which caused 100% mortality.  The concentration that caused 100% mortality in 
P. promelas was 400 ppb. 
Nakamura et al. (2008) documented the LC50s of Oryzias latipes (Japanese medaka) as 
6000 at a pH of 7, 1000 at a pH of 8, and 200 at a pH of 9. In the current study, all test organisms 
had 96 hour LC50s much lower than those found at pHs 7 and 8; however, the LC50 at the pH of 
9 (200 ppb) was identical to the fish P. promelas (200 ppb) and the water flea D. pulex (200 ppb) 
and comparable to the fish M. beryllina (500 ppb) and the shrimp M. bahia (500 ppb). 
Chronic Values  
The chronic value was statistically elected from the NOEC - LOEC ratio according to the 
Steel’s Many One Rank Hypothesis Test.  By definition, this concentration is not considered to 
be harmful thus it should be lower than the EC50. 
Ethinyl estradiol chronic values.  The most sensitive species based on Ch.V:  C. dubia 
(300 ppb) > M. bahia (400 ppb) > M. beryllina (1000 ppb) > P. promelas (2000 ppb) > D. pulex 
(4000 ppb).  
All test organisms exposed to EE2 follow the idea that the EC50 is usually slightly higher 
than Ch.V. (Figure 15).  In C. dubia and M. bahia the EC50 was only slightly higher than the 
Ch.V. in consequence of the normal dose response curve as well as the NOECs causing more 
than 20% mortality LOECs causing about60-68% mortality and the highest concentrations 
bringing about 100% mortality. The EC50 of P. promelas is more sizable than the Ch.V. 
attributable to only 40% mortality occurring in the LOEC which was the highest concentration 
and only 8% mortality in the NOEC. The LOEC D. pulex also produced 40% mortality 
formulating an EC50 more considerable than the Ch.V. Additionally, a hormetic response was 
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observed from the lowest concentration throughout the NOEC.  The EC50 of M. beryllina was 
fairly larger than the Ch.V. because the LOEC had 43% with next highest concentration 
producing 100%.  
 
Figure 15.  A comparison of the statistically analyzed EC50s and chronic values of organisms 
after 96 hours of exposure to ethinyl estradiol.  
 
Fluoxetine chronic values.  All the Ch.V.s were pretty close ranging from 70-300 ppb.  
The most sensitive Ch.V:  M. bahia (70 ppb) > P. promelas (100 ppb) > C. dubia (200 ppb) > D. 
pulex (200 ppb) > M. beryllina (300 ppb). 
Based on the definition of the chronic value the EC50 is usually slightly higher than 
Ch.V.  (Figure 16).  The EC50 is lower than Ch.V. in C. dubia because there was 100% mortality 
in concentrations less than the NOEC (60%) and LOEC (95%).  Additionally, in D. pulex, there 
was 80% in the NOEC and 90% in the LOEC and 10-15% in control and lesser concentrations.   
In P. promelas the EC50 was greater than the Ch.V. despite the drastic change in mortality 
between the three highest concentrations which included the NOEC and the LOEC, which only 
caused 40% mortality.  The much higher EC50s in M. bahia and M. beryllina for can be 
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attributed to the disruption in the normal dose-response curve and because the LOEC is not the 
first significantly different concentration. 
 
Figure 16. A comparison of the statistically analyzed EC50s and chronic values of organisms 
after 96 hours of exposure to fluoxetine. 
 
Classification of Lethal Effects 
Dose-response relationships are usually very well documented in the intended target of 
the pharmaceutical (i.e. humans or target animals).  However, the uncertainty with nontarget 
organisms is great due to changes in dosage, exposure time, response, pharmacokinetic action, 
and external interferences (O’Conner et al. 2002).  Based on classification by Annex VI to the 
European Community legislation (Directive 67/548/EEC) pharmaceuticals can be categorized by 
the expected toxicity on the ecosystem based on LC50, log Kow, and solubility in water.  
R50:  ―Very toxic to aquatic organisms.‖ – Acute toxicity [LC50 (fish) or EC50 (daphnia)] ≤ 
1000 ppb. 
 
R50 and R53:  ―Very toxic to aquatic organisms and may cause long-term adverse effects in the 
aquatic environment.‖  
– Acute toxicity ≤ 1000 ppb, and the compound is not readily degradable, or log Kow ≥ 3 
(unless experimentally derived BCF ≤100). 
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R51: ―Toxic to aquatic organisms.‖  
– Acute toxicity > 1000 ppb and ≤ 10000 ppb. 
 
R51 and 53: ―Toxic to aquatic organisms and may cause long-term adverse effects in the aquatic 
environment.‖  
– Acute toxicity > 1000 ppb and ≤ 10000 ppb and the compound is not readily 
degradable, or log Kow ≥ 3 (unless experimentally derived BCF ≤ 100). 
 
R52: "Harmful to aquatic organisms."  
– Acute toxicity > 10000 and ≤ 100,000 ppb. 
 
R52 and 53: ―Harmful to aquatic organisms and may cause long-term, adverse effects in the 
aquatic environment.‖ 
– Acute toxicity >10000 ppb and ≤ 100000 ppb and the compound is not readily 
degradable, or log Kow ≥ 3(unless experimentally derived BCF ≤100). 
 
R53: ―May cause long-term adverse effects in the aquatic environment.‖  
– Solubility less than 1000 ppb, not readily degradable, or log Kow ≥3 (unless 
experimentally derived BCF ≤ 100). 
 
Simply based on the EC50s ethinyl estradiol was very toxic (R50) in C. dubia (400 ppb) 
and in M. bahia (600 ppb).  Ethinyl estradiol is toxic (R51) to D. pulex (6000 ppb) and M. 
beryllina (2000 ppb) and harmful (R52) to P. promelas (10000 ppb). 
Simply based on the acute toxicity fluoxetine was very toxic (R50) to all test organisms: 
C. dubia (5 ppb), P. promelas (200 ppb), D. pulex (200 ppb), M. bahia (500 ppb), and M. 
beryllina (500 ppb). 
Table 17. Expected toxicity classification based on the Annex VI to the European Community 
legislation of EE2 and FLX according to EC50 results of the current study. 
Organism 
EE2 
EC50  
(ppb) 
Classification 
Toxic 
Potential 
FLX 
EC50  
(ppb) 
Classification 
Toxic 
Potential 
C. dubia 400 R50 very toxic 5 R50 very toxic 
D. pulex 6000 R51 toxic 200 R50 very toxic 
P. 
promelas 
10000 R52 harmful 200 R50 very toxic 
M. bahia 600 R50 very toxic 500 R50 very toxic 
M. 
beryllina 
2000 R51 toxic 600 R50 very toxic 
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The solubility of ethinyl estradiol in water was reported as 11.3 x 10
4
 ppb (Yalkowsky 
and Dannenfelser 1992). The maximum solubility of fluoxetine in water was noted as 14 x 10
6
 
ppb (O'Neil 2001).  Additional solubilities were reported as and 15.0 x 10
6
, 6.84 x 10
6
, and 5.47 
x 10
6
 in the respective pHs of 5, 7, and 9 (Eli Lilly and Company 2005). Therefore, both drugs 
―may cause long-term adverse effects in the aquatic environment‖ (R53) based on the fact that 
their solubilities are less than 1000 ppb and not readily degradable. 
The drugs may also be classified as R53 if the log Kow ≥3. The reported Log Kow for 
ethinyl estradiol was 3.67 (Hansch et al. 1995) with a predicted log Kow of 4.12 using the 
Ecological Structure Activity Relationships program (ECOSAR) (Sanderson et al. 2004). 
Depending on which steroisomer is used for fluoxetine, the log Kow may differ slightly.  For 
example, Eli Lilly and Company (2005) reported the log Kow for fluoxetine as 1.0, 1.8, and 2.6 at 
pH 5, 7, and 9 respectively.  Brooks et al. (2003a) calculated values using ACD/Labs software 
version 5.0 in Toronto, Ontario, Canada which included 1.25, 1.57, and 4.30 at pH 2, 7, and 11 
respectively. ECOSAR predicted the log Kow of fluoxetine HCl as 4.65 (Sanderson et al. 2004). 
Consequently, EE2 is classified as R53 based on the log Kow as is FLX at pHs greater than 9.  
However, according to ECOSAR the log Kow of FLX is greater than 3 at any concentration.  
The higher the log Kow (octanol-water coefficient) the more hydrophobic the compound 
is and the greater probability for bioaccumulation. Lipophilic xenobiotics (log Kow >3) are 
absorbed into fish bloodstream primarily across the gills (Kreke and Dietrich 2008).     
Sublethal Effects of Ethinyl Estradiol and Fluoxetine 
This study extended beyond lethality through the observation of sublethal effects which 
are not required for acute test methods.  Abnormalities observed during the test were 
documented and concentration boundaries were established for sublethal effects. EE2 and FLX 
induced effects on these standard EPA organisms.   
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Alteration of serotonin, dopamine, and estrogenic hormones.  Ethinyl estradiol and 
fluoxetine have the potential to alter serotonin, dopamine, and estrogenic hormones.  Therefore, 
biological activities encompassing these chemicals could explain the various and in some cases, 
similar behaviors/abnormalities observed in the current study.  Estrogens also have the potential 
increase serotonergic activity in Tilapia (Tsai and Wang 1997) and extracellular dopamine in 
Rats (Disshon et al. 1998). Estrogens stimulate sensitivity of dopamine receptors in vertebrate 
central nervous systems resulting in an increase of the catecholamine (Kelly et al. 2003; 
Mermelstein et al. 1996). Knoll et al. (2000) demonstrated that in estrone (E1), dopamine release 
is inhibited resulting in low levels of dopamine.  However, Kelly and Wagner (1999) determined 
that the natural estrogen E2 estradiol stimulates dopamine release resulting in more lethargic 
activity.   
Bymaster et al. (2002) state that norepinephrine and dopamine levels in mammals are 
also increased after acute dosing with fluoxetine.  Most SSRIs only increase the amount of 
extracellular concentrations serotonin (Bymaster et al. 2002; Kreke and Dietrich 2008), thus 
making FLX a unique pharmaceutical.  Fluoxetine increased extracellular concentrations of 
serotonin, norepinephrine and dopamine after acute dosing.  The 242 nM concentration of 
monoamines were sufficient to block 5-HT receptors which could explain the increase of 
catecholamines (Bymaster et al. 2002).   
Fluoxetine has significantly increased female circulating steroid concentrations in aquatic 
organisms (Foran et al. 2004) perhaps causing organisms exposed to FLX to exhibit 
abnormalities also seen after EE2 exposure.  
Control of the circandian system.  Under control of a number of neurotransmitters 
including but not limited to serotonin and dopamine (Fingerman et al. 1994) are distal retinal 
pigment hormones which modulate the amount of pigment present in the compound eyes.  This 
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enables organisms to adapt and differentiate between light and dark intensities (Beltz 1988). If 
animals are unable to and measure and interpret day duration, necessary activities/functions 
modified by the circandian system will be disrupted. Changes in normal body chemicals can 
modify signaling pathways resulting in variations in behavior (Kreke and Dietrich 2008).  As 
evident by their swimming behavior, D. pulex and P. promelas appeared confused and 
disoriented after EE2 exposure.  This behavior was monitored in all test organisms exposed to 
FLX.  In this case it appears that there was a disruption in the organisms’ sensory perception due 
to variations in neuromodulators.  
Observed changes in behavior.  Abnormal behaviors observed in all exposed organisms 
included unresponsiveness, irregular swim patterns, erratic activity, convulsions, and changes in 
aggression. Changes in locomotor activity could be the result of nueromodulatory effects 
resulting from the dopaminergic levels following estrogenic administration (McGeea et al. 
2009).   
Generally speaking organisms exposed to ethinyl estradiol and fluoxetine demonstrated 
lethargic behavior which became more pronounced as time and concentration increased.  The 
decrease in activity was correlated with the approaching mortality of the organisms. C. dubia and 
P. promelas became lethargic during the first 24 hours of exposure with activity decreasing as 
time and concentrations of EE2 increased. D. pulex and M. beryllina also displayed a decrease in 
activity correlating with the increased time and concentrations with immobilization becoming 
extremely prominent at 72 hours. All in all, as concentration increase immobilization became 
more prominent.  Studies by Jaser et al. (2003) observed swim inhibition in Ceriodaphnia 
reticulate and Sida crystalline (water fleas) after 24 hours of exposure to ethinyl estradiol 
yielding EC50s of 2000 ppb and less than 4000 ppb respectively.    
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Table 18.  Effects on catatonic behavior observed in test organisms resulting from ethinyl 
estradiol or fluoxetine exposure. 
Organism Chemical Catatonic behavior Dose 
(ppb) 
Ceriodaphnia dubia  
 
EE2 More prominent as time and 
concentrations increased  
200 -7000 
Ceriodaphnia dubia. FLX More prominent as time and 
concentrations increased 
20 – 200 
Daphnia pulex EE2 More prominent as time and 
concentrations increased 
> 300  
Daphnia pulex FLX Immobilization  200  
More prominent as time and 
concentrations increased 
500  
Pimephales promelas EE2 More prominent as time and 
concentrations increased 
400 – 3000 
Pimephales promelas FLX More prominent as time and 
concentrations increased 
 
Stationary vertical positioning 20 - 40  
Menidia beryllina EE2 More prominent as time and 
concentrations increased 
100 – 3000 
Mysidopsis bahia FLX More prominent as time and 
concentrations increased  
 
Menidia beryllina FLX  More prominent as time and 
concentrations increased 
 
 
Stanley et al. (2007) documented similar activity in which FLX caused immobilization in 
Daphnia magna (water flea). P. promelas and M. beryllina exposed to fluoxetine were hovering 
at the surface demonstrating very little activity beginning at test initiation. All crustaceans (water 
fleas and M. bahia) were statically positioned around the edge of the beaker.  In the current 
study, P. promelas and M. beryllina demonstrated catatonic behavior and vertical positioning 
which became more common in elevated concentrations as the test transpired.  Gaworecki and 
Klaine (2008) documented similar tendencies in hybrid striped bass exposed to 200 ppb of FLX.  
In addition, elevated serotonin amounts, after exposure to SSRIs, have been connected with 
submissive behavior in rainbow trout (Øverli et al. 2004) and in Japanese medaka which also 
displayed nonresponsiveness (Foran et al. 2004).  Western mosquitofish remained at the surface 
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and lay on their sides with little or no swimming movement after acute exposure with lesser 
concentrations producing less severe effects (Henry and Black 2008).  
Initial increases of dopamine can cause agitation and aggression followed by depression.  
Increased dopamine in the motor circuits will tend to produce random, involuntary movements 
and muscle twitching along with possible abnormal posturing.  After EE2 regiments, the restless 
behavior of P. promelas included shaking and trembling which decreased with time and usually 
ceased after 24 hours.  The more severe tremors noted after larger dosing of EE2 and FLX in M. 
beryllina correlated with fatality.  These organisms exhibited apparent CNS toxicity 
characterized by convulsing and seizing.  
Impulsive and inconsistent activity was observed in D. pulex and P. promelas at the 
beginning of the FLX test. Given the nature of dopamine, it would be assumed that activity 
would increase as shown by the rotations and spiraling observed in D. pulex exposed to FLX and 
M. bahia administered both drugs.  Coiled swimming was associated with the warped tails and/or 
spines of P. promelas subjected to both drugs and M. bahia administered FLX. 
All species exhibited fits of agitation in higher concentrations of FLX which could be due 
to increased dopamine levels during first 24 hours. Jumpiness was observed in all species at 
lesser concentrations of FLX and ceased quickly with time.  Lower concentrations of FLX 
launched restless behavior of marine organisms in just 24 hours.  For water fleas, restless 
behavior in lower concentrations of FLX began at 96 hours. 
Table 19.  Effects on abnormal behavior observed in test organisms resulting from ethinyl 
estradiol or fluoxetine exposure. 
Organism Chemical Abnormal Behavior Dose 
(ppb) 
Ceriodaphnia dubia  FLX Very active and anxious 7  
Daphnia pulex EE2 Swimming around the 
parameter of the beaker   
300 and 1000  
Crashed into the sides of the 
beakers and attempted escape   
5000  
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(Table 19 continued) 
Organism Chemical Abnormal Behavior Dose 
(ppb) 
Daphnia pulex FLX Jerky swimming motions 
 
Combating and/or mating 
60  
Rotating backwards 
 
Swimming in circles around 
beaker   
100  
Pimephales promelas EE2 Frantic  800  
Swimming inconsistently 
throughout the water column 
 
Jumpy 
  
Disoriented 
400 and 2000  
Pimephales promelas FLX Stationary vertical positioning  20 – 40 
Disoriented  
 
Restless behavior  
10 – 90  
Corkscrew swimming pattern 90 – 200 
Mysidopsis bahia FLX More active  
 
190  
Tumbling 100 and 800  
Crooked tails  100  
Menidia beryllina  EE2 Extremely restless behavior  400  
Flipping backwards 2000  
Convulsions and Seizures 2000 and 3000 
Menidia beryllina  FLX Agitation    
 
Higher 
concentrations 
Convulsions and seizures 900 and 2000  
 
Observed changes in feeding.  The neurotransmitter serotonin additionally functions as 
a hormone which can directly impact the immune system and alter appetite (Fent et al. 2006; 
Barton et al. 2002).  Goldfish showed a significant reduction in food intake when injected with 5-
HT (serotonin) (de Pedro et al. 1998). Exposure to FLX decreased growth and feeding rates in 
fathead minnow (Stanley et al. 2007). In the current study, M. bahia decreased feeding in 1000-
2000 ppb EE2 and at concentrations above 200 ppb FLX.   
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Table 20.  Effects on feeding habits observed in test organisms resulting from ethinyl estradiol or 
fluoxetine exposure. 
Organism Chemical Response Dose 
(ppb) 
Mysidopsis bahia  EE2 
Decreased feeding 1000-2000  
Artemia, were alive 
and very active 
1000-2000  
Mysidopsis bahia FLX Decreased feeding  > 200  
 
Observed changes in aggression.  Metcalfe et al. (2001) deduce that serotonin is the 
antiaggressive agent in fish.  The increased concentrations of EE2 and FLX caused a decrease in 
probing and hostility in P. promelas and M. bahia.  Those allotted higher concentrations of these 
drugs ceased this disruptive behavior usually within 24 hours.  However, antagonism 
documented in lower concentrations occurred closer to test termination.  In accordance with 
submissive activity, cannibalistic casualties also subsided.  M. bahia are naturally cannibalistic; 
these tendencies were observed in both tests.  After EE2 exposure the absence of D. pulex and 
the apparent mutilation of deceased P. promelas were assumed to be prompted by the surviving 
organisms. 
Some aquatic species require aggressive behaviors to define hierarchical status and 
dominance in reproduction.  By omitting these behaviors during sensitive periods of reduction, 
genetically less desirable organisms would mate arguably producing less desirable or unhealthy 
offspring thus upsetting the balance of natural selection (Kreke and Dietrich 2008).   
Table 21.  Effects on aggressive behavior observed in test organisms resulting from ethinyl 
estradiol or fluoxetine exposure. 
Organism Chemical Response Dose 
(ppb) 
Daphnia pulex EE2 Missing organisms 300  
Eaten by survivors    300 and 1000  
Pimephales promelas EE2 Aggressive and probing actions of 
inactive organisms 
800 and 2000    
Damage and mutilation of 
deceased   
100 and 200 
Injured underbelly 3000  
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(Table 21 continued) 
Organism Chemical Response Dose 
(ppb) 
Pimephales promelas FLX Probing of inactive organisms 90 – 200  
Mysidopsis bahia  EE2 Aggressive behaviors and hostility  80 and 1000  
Cannibalism  ≤ 300 and ≥ 600   
Mysidopsis bahia  FLX Cannibalism  > 50 < 
 
Observed changes in fecundity.  C. dubia and D. pulex exhibited increase in fecundity 
though sexual maturity is not expected to occur this early.  Therefore, it can be assumed that 
ethinyl estradiol stimulates egg production. A minute number of D. pulex were observed mating 
in both EE2 and FLX; however this behavior cannot be confirmed.  It is important to note that 
although the Daphnia population is usually made up entirely of females, under times of stress 
male daphnids are produced in relatively small numbers with the propriety to mate (EPA 2002). 
As a response to stress, species may produce offspring as early as possible in order to ensure 
survival (Jaser et al. 2003).     
Table 22.  Effects on fecundity or reproduction observed in test organisms resulting from ethinyl 
estradiol exposure. 
Organism Response Dose 
(ppb) 
Ceriodaphnia dubia  1 offspring in each container 
  
Larvae in the brood chamber 
of deceased organisms  
200  
Offspring present 400  
Daphnia pulex Offspring 600 and 3000 
Eggs in brood chamber 1000  
Ephippia   > 3000  
Eggs not released  10000  
 
Observed changes in growth and development.  Accelerated maturation was observed 
in C. dubia, D. pulex, P. promelas, and M. bahia by evidence of coloration and/or larval 
classification exposed to EE2.  The growth increase of C. dubia, D. pulex, and M. bahia assigned 
lower concentrations can possibly be attributed to femization since females of these species are 
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larger (EPA 2002).  It was assumed that molting and growth was inhibited in these species at 
higher concentrations based on size.  Additionally, ephippia, typically released during the molt 
cycle, were first observed within 24 hours to 10000 ppb on the tails of D. pulex.  The process of 
development and molting is managed by constituents of the endocrine system.  Simazine, a 
known endocrine disruptor, was shown to interfere with the molt cycle of D. pulex (Fitzmayer et 
al. 1982).  
Previously documented research shows that EE2 can have an effect on growth; however, 
these organisms were exposed for longer periods of time than in the current study.  Still, it 
appeared that acute exposure to EE2 can affect growth. C. dubia in 7 ppb (NOEC for FLX 
mortality) were larger than control organisms or those exposed to other concentrations.  This low 
dose may stimulate growth while higher doses may inhibit growth. It is difficult to make this 
assumption because so many of the organisms died at elevated concentrations.  D. pulex 
demonstrated a different effect in which higher concentrations appeared to stimulate growth. 
Table 23.  Effects on growth and development observed in test organisms resulting from ethinyl 
estradiol or fluoxetine exposure. 
Organism Chemical Response Dose 
(ppb) 
Ceriodaphnia dubia  FLX Larger size  7  
Daphnia pulex EE2 Larger size 1000  
Daphnia pulex FLX Larger size  900 and 1000 
Pimephales promelas EE2 Accelerated maturation  
Mysidopsis bahia EE2 Larger size 200  
Mysidopsis bahia FLX Larger size 190  
Menidia beryllina EE2 Accelerated maturation  100-200 
Mature pigmentation  2000  
 
Observed changes in color.  A number of species exhibiting decrease or absence in 
color after EE2 exposure was documented in Danio rerio (zebrafish) (Bogers et al. 2006), 
Poecilia reticulate (guppy) (Nielsen and Baatrup 2006), and Pomatoschistus minutes (sand goby) 
(Robinson et al. 2003).  The dispersion or accumulation of pigment hormones determines the 
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coloration of organisms.  These chromatophores are under control of a number of 
neurotransmitters including but not limited to serotonin and dopamine (Fingerman et al. 1994).  
As concentrations of EE2 and FLX increased, pigmentation decreased in D. pulex, P. promelas, 
M. bahia, and M. beryllina.  Larval classification in EPA methods suggested that P. promelas in 
levels above 800 ppb EE2 matured faster; however, they remained pale in color. Their apparent 
transparency could stem from deprivation of hemoglobin (USEPA 2002). Henderson et al. 
(1981) noted a hemoglobin deficiency in minnows exposed to Hydrazine, an endocrine disruptor 
widely used in industrial manufacturing.  
Table 24.  Effects on pigmentation observed in test organisms resulting from ethinyl estradiol or 
fluoxetine exposure. 
Organism Chemical Response Dose  
(ppb) 
Pimephales promelas EE2 Opaque pigmentation > 800 
Mysidopsis bahia EE2 Denser coloration  200  
Mysidopsis bahia FLX Decreased pigmentation > 200 
Menidia beryllina EE2 Denser pigmentation at 
the head 
100-200 
Mature pigmentation 2000 
 
Observed abnormalities.  After EE2 exposure P. promelas had spinal deformities.  
Deformation of the vertebrae after estrogen dosing was reported in Fundulus heteroclitus 
(mummichog) and Pimephales promelas (fathead minnow) (Lange et al. 2001; Warner and 
Jenkins 2007). Lange et al. (2001) also reported the occurrence of distended abdomens.    
Protruding abdomens occurred in D. pulex, P. promelas, and M. beryllina and became more 
pronounced at elevated concentrations of EE2.  Interestingly, swollen abdomens in these species 
were also triggered with FLX dosing.  Fluoxetine also caused warped vertebrae in P. promelas 
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and M. bahia. Foran et al. (2004) reported that Japanese medaka exposed to FLX also possessed 
spinal curvatures. 
Table 25.  Abnormalities observed in test organisms resulting from ethinyl estradiol or fluoxetine 
exposure. 
Organism Chemical Response Dose 
(ppb) 
Daphnia pulex EE2 Cloudy water 10000  
Daphnia pulex FLX Engorged abdomens  900 and 1000  
Pimephales promelas EE2 Engorged swim bladders   
 
Injured underbelly 
3000 
Pimephales promelas FLX Engorged abdomens   
 
Crooked spines  
 
Larger and lighter swim bladders 
90 – 200 
Menidia beryllina EE2 Engorged abdomens   200-400  
Menidia beryllina FLX Engorged abdomens   
 
A rationalization of the abdominal protrusion occurring in the two fish species could be 
due to possible overinflation of swim bladders.  A swim bladder or air bladder is a large, thin-
walled sac located in the dorsal portion of the body cavity that functions as a buoyant float, a 
sound producer and receptor, and a respiratory organ. It allows the fish to move up and down 
through the water column and remain at a specific water depth without wasting energy 
swimming. The fish exposed to both drugs had lighter colored swim bladders thus enforcing the 
idea that hemoglobin is lacking.  Hemoglobin allows fish to fill or empty the swim bladder. This 
organ is mostly inflated at night when organisms trying to escape predators rise to the surface of 
the water and take in air (Büke et al. 2005).  The circandian rhythmic offset due to changes in 
serotonin amounts could explain why the organisms were floating on the surface.  Overinflation 
of the swim bladder causes organisms to float to the surface of the water and in turn they die of 
starvation because they stop eating (Chatain 1994; Planas and Cunha 1999) as observed after 
EE2 and FLX exposure.  High levels of catecholamines have been closely linked to Swim 
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bladder Stress Syndrome (SBSS), characterized by overinflation of the swim bladder, in which 
no other anatomical alterations are apparent (Kolbeinshavn & Wallace 1985).  Generally, 
observed swim bladder size increased as concentrations increased.  
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CONCLUSIONS 
Every year people use thousands of tons of drugs to treat illnesses, to prevent unwanted 
pregnancy, or to face the stresses of modern life.  This appraisal is steadily increasing at an 
exponential rate.  The actual amounts consumed are based on estimates and are probably much 
more abundant than reported because annual sales data does not include internet sales. Even after 
extensive metabolism these reasonably stable active pharmaceutical ingredients are typically 
unaltered with large portions of the parent compound being excreted. The metabolites may return 
to the original parent compound either during sewage treatment or through environmental 
transformations.  Sewage treatment plants are not designed to remove pharmaceuticals and the 
active pharmaceutical ingredients are conceived to withstand degradation.  These oppositions 
increase the potential for these compounds to remain in animal tissue and bioaccumulate 
enforcing biomagnifications and bioconcentrations.  Moreover, the pharmaceutical industry is 
producing more effective active APIs by increasing potency, bioavailability, and degradation 
resistance.  For these reasons they should be regarded as contaminants of concern.   
In terms of other man-made pollutants environmental pollutants, pharmaceuticals 
exemplify a minuscule fraction of harmful contaminants present in the aquatic environment.  
Ethinyl estradiol and fluoxetine, two of the most popular pharmaceuticals in the United States 
have been available for decades, making them present in the environment since their introduction 
to the market.  Because APIs are typically present in extremely low concentrations it is through 
recent advances in analytical instrumentation and techniques that their incidence has been 
validated.  This does not belittle APIs potential to cause harm to the environment because 
pharmaceuticals are formulated to generate maximum responses at minimal amounts. 
Environmental concern is not exclusively based on high production rates.  Risk 
assessment focuses on the chemicals’ properties and behavior in the environment such as 
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degradation resistance, accumulation potential, toxicity potential, and effectiveness on biological 
key functions such as hormone interference, reproduction, growth disturbance, etc. which are all 
properties of EE2 and FLX.  
After test termination, mortality curves were analyzed to quantify 96 hour EC50s, 
NOECs, LOECs, and Ch.V.s for each of exposed to ethinyl estradiol and fluoxetine. Additionally 
the acute toxic responses were assessed, compared, and contrasted for the five standard EPA test 
organisms.   
A broad range of effects and the ability for bodily chemicals to neutralize and return to 
normal after exposure suggests that a traditional dose-response relationship may not be expected.  
Higher mortality did not always correlate with increased concentration as evident by the 
hormetic responses of organisms:   P. promelas and M. beryllina and a slightly in D. pulex and 
M. bahia after EE2 exposure and in C. dubia at 48 hours (causing 100% mortality at 96 hours) 
and in M. bahia after FLX exposure and slightly in D. pulex. A normal dose-response was 
observed in dose-response plots of C. dubia exposed to ethinyl estradiol and in D. pulex, P. 
promelas, and M. beryllina exposed to fluoxetine. 
At a similar EE2 concentration of 2000 ppb, mortalities included P. promelas (8%), D. 
pulex (30-20%), M. beryllina (42.5%), M. bahia (95-100%) and C. dubia (100%).   
The mortalities at 100 ppb of FLX included D. pulex (10%), P. promelas (3-40%), M. 
beryllina (20%), M. bahia (47.5 – 45%), and C. dubia (60%). 
The lowest concentrations of EE2 causing 100% mortality were as follows:  C. dubia 
(900 ppb), M. bahia (2000 ppb), M. beryllina (3000 ppb), P. promelas (8000 ppb), and D. pulex 
(10000 ppb).  
The lowest concentration of FLX causing 100% were as follows: C. dubia (20 ppb), P. 
promelas (400 ppb), D. pulex (900 ppb), M. bahia (1000 ppb), and M. beryllina (2000 ppb). 
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EE2 yielded higher EC50s and has been detected at levels greater than FLX which 
produced lower lethal concentrations.  The most sensitive species depends on the endpoint.  C. 
dubia is the most sensitive species based on EC50 for EE2 and FLX.  Based on EC50 the most 
resilient species was P. promelas for EE2 and M. beryllina for FLX. 
The most sensitive species based on EC50 EE2:  C. dubia (400 ppb) > M. bahia (600 
ppb) > M. beryllina (2000 ppb) > D. pulex (6000 ppb) > P. promelas (10000 ppb).  
The most sensitive species based on EC50 of FLX: C. dubia (5 ppb) > P. promelas (200 
ppb) > D. pulex (200 ppb) > M. bahia (500 ppb) > M. beryllina (500 ppb). 
The most sensitive species exposed to EE2 based on chronic value:  C. dubia (300 ppb) > 
M. bahia (400 ppb) > M. beryllina (1000 ppb) > P. promelas (2000 ppb) > D. pulex (4000 ppb).  
The most sensitive species exposed to FLX based on chronic value:  M. bahia (70 ppb) > 
P. promelas (100 ppb) > C. dubia (200 ppb) > D. pulex (200 ppb) > M. beryllina (300 ppb). 
The Ch.V. is based on the ratio of the NOEC and LOEC; because it is the concentration 
that is considered ―safe‖ it should be lower than EC50.  This rule pertains to all organisms 
exposed to EE2. Freshwater species exposed to FLX broke this rule which can be explained on a 
case by case situation.  While still following the rule, the marine species exhibited much higher 
EC50s. This can be attributed to the disruption in dose-response of M. bahia and M. beryllina 
and the fact that the LOEC is not the first significantly different concentration. 
Target receptors and/or biomolecules are present in humans and mammals are also 
present a number of vertebrate and invertebrate nontarget organisms.  Hence, these nontarget 
organisms can potentially experience similar effects documented in mammalian toxicity tests.    
These two drugs presented unanticipated and in many cases similar effects to the 
organisms even after 96 hours. Exposure to these chemicals can potentially alter levels of 
serotonin and dopamine and affect hormone production consequently signaling changes in 
 
 
102 
behavior and normal development.  Changes in behavior could be due to nueromodulatory 
effects attributable to the changes in dopamine and serotonin levels. M. beryllina exhibited CNS 
toxicity characterized by convulsing and seizing which correlated with fatality in both drugs.   
Normal activity decreased with increased concentration and time (all org. all drugs). 
Abnormal behaviors observed in both chemicals included unresponsiveness, irregular swim 
patterns, erratic activity, and decreased aggression.  All in all, as concentration increase 
immobilization became more prominent for both drugs.  
Both chemicals caused distended abdomens in P. promelas M. beryllina, and D. pulex.  
This affected swim behavior in the sense that as abdomen became more pronounced, 
immobilization was more prominent.  Also affecting swim behavior was the spinal deformities 
observed in M. bahia exposed to FLX and P. promelas after exposure to both drugs. 
Naturally cannibalistic M. bahia exhibited decreases in feeding and aggression when 
exposed to elevated concentrations of both pharmaceuticals.   Cannibalisms occurred at higher 
concentrations for EE2 and FLX.  Aggression decreased with concentration and time in M. bahia 
exposed to both drugs. P. promelas began probing less active organisms in both drugs. 
Organisms in lower concentrations ceased this activity but continued in elevated doses.  
P. promelas FLX aggression increased with time in lower concentrations.   
Some aquatic species require aggressive behaviors to define hierarchical status and 
dominance in reproduction.  Modifications in any essential behaviors as well as transformations 
in growth and development during sensitive periods of reduction could lead to genetically less 
desirable organisms to mate. Arguably less desirable or unhealthy offspring would be produced 
thus upsetting the balance of natural selection.  The two species of water fleas (C. dubia and D. 
pulex) exhibited different mortality curves but both displayed induction of fecundity when 
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exposed to EE2.  Although M. bahia demonstrated a similar in mortality curve to C. dubia, 
mysid did not exhibit any offspring after EE2. 
Ethinyl estradiol accelerated maturation in lower concentrations. Because the test 
organisms, have relatively short life cycles, are not supposed to mature this fast.  Higher 
concentrations increased maturity a slightly but delayed growth possibly by decreasing the 
ability to molt.  The lower concentrations produced larger C. dubia, D. pulex, and M. bahia. 
Organisms exposed to higher concentrations of EE2 and FLX lacked pigment, except one M. 
beryllina exposed to EE2 in which case exhibited maturity by coloration.   
The hypothesis was that complex organisms would exhibit less lethality at higher 
concentrations.  As this hold true in some cases. P. promelas was the most resilient species based 
on similar concentrations and the EC50.  D. pulex was the most resilient in terms of 100% and 
Ch.V.  C. dubia was the most sensitive in terms of similar concentration, 100% mortality, EC50, 
and Ch.V.    
The results in the present study confirm pharmaceuticals can produce lethality of non-
target organisms through acute exposure.  Similar mortality patterns were observed between C. 
dubia and M. bahia and between P. promelas, D. pulex, and M. beryllina.    
It was expected that similar species would exhibit similar mortalities to one another.  
While exposure to EE2 caused C. dubia and M. bahia (both crustaceans) to exhibit similarities in 
terms of similar dose-response, EC50s, and Ch.V.s, the D. pulex (the other species of water flea) 
was much more resilient and in some cases the most resilient organism.  The two fish species had 
similarities in the dose response curve.  At 3000 ppb M. beryllina had 100% mortality while P. 
promelas had only 40% mortality making it very resilient.  Interestingly at the lesser 
concentrations, 100 - 800 ppb both fish exhibited identical hormetic changes in mortality. It 
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appears that D. pulex sensitivities were in between these two fish in similar concentrations and 
EC50.  The sensitivities were higher than fish in 100% and Ch.V.  In all cases though,  
M. beryllina was more sensitive than P. promelas and D. pulex.  In all cases C. dubia was most 
sensitive with M. bahia being the second most sensitive. 
Exposure to FLX caused C. dubia to be the most sensitive in 100%, similar 
concentration, and EC50.  In Ch.V. M. bahia was the most sensitive with C. dubia being 3
rd
.  
The most resilient species in 100% and EC50, and Ch.V. was M. beryllina, The most resilient 
based on similar concentrations was D. pulex.  In 100% D. pulex and M. bahia (crustaceans) 
were similar along with M. beryllina.  All these were more resilient than C. dubia and P. 
promelas.  In similar concentrations, D. pulex had similar mortalities to the two fish which were 
more sensitive than the water flea.  The C. dubia and M. bahia were similar. D. pulex and P. 
promelas were similar in EC50 with the other freshwater species being most sensitive.  However, 
C. dubia had an EC50 closer to P. promelas. The two marine species, M. bahia and M. beryllina 
were similar in EC50s.   
It has been apparent that these pharmaceuticals not only elicit lethality but also abnormal 
behaviors that have a number of possible explanations or in some cases, cannot be explained. 
Simply observing lethality alone is not a sufficient enough endpoint to determine potential 
effects on environment. It is the unpredicted effects that are causing harm to ecosystems.  Ethinyl 
estradiol and fluoxetine have the potential to alter serotonin, dopamine, and estrogenic 
hormones.  Therefore, biological activities encompassing these chemicals could explain the 
various and in some cases, similar behaviors/abnormalities observed in the current study.  
Abnormal behaviors observed in all exposed organisms included unresponsiveness, irregular 
swim patterns, erratic activity, convulsions, and changes in aggression. Generally speaking 
organisms exposed to ethinyl estradiol and fluoxetine demonstrated lethargic behavior which 
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became more pronounced as time and concentration increased.  All in all, as concentration 
increase immobilization became more prominent. Generally, observed swim bladder size 
increased as concentrations increased.  
Traditional toxicity tests are designed usually designated specific mortality endpoints to 
assess. More specific toxicity analysis should be developed implementing the available 
knowledge that is generated during the pharmaceutical drug development process (e.g. 
mechanisms of action, pharmacokinetic behavior and metabolism, target organs and side effects 
in mammals). 
Aside from the major mode of action, which in many cases are completely understood for 
humans, pharmaceuticals have multiple minor modes of actions.  However, given what we do 
know about the drugs, experiments should be targeted towards known target modes of action 
based on the assumption of similar modes of action in different species.  Although a 
pharmaceutical is projected to execute a specific pathway does not mean it will; the present study 
has confirmed this idea.  Nontarget tissues and organs can become disrupted complicating the 
strategy to analyze potential effects.   
Although animals are exposed to a multitude of chemical combinations, studies rarely 
give effects on mixtures because it is difficult to evaluate which drug may cause which 
unanticipated effect.  It is important to understand how these drugs act as single exposure before 
taking into account mixtures.  These time consuming tests are much more complex, extensive, 
and expensive and usually only justifiable at environmentally present concentrations.  Also 
mixture effects are most often anticipated by the idea of concentration addition in which the 
combined toxicity is derived from the addition of the individual concentrations of each 
compound.  With this said, in the current study, species exhibited similar sublethal endpoints in 
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both drugs. With this in mind, hypothetically concentrations that do not illicit lethality can cause 
sublethal effects and based on additions can occur at environmentally detected levels.  
It is difficult to anticipate outcomes based solely upon the drug’s intentional function or 
an organism’s classification.  Simple observations during acute tests can aid in analysis for 
environmental risk and eventually aid in quantifying/development for new test regulations. Even 
though some effects may not be statistically relevant this does not lessen their importance.  Even 
subtle alterations in normal life progressions, control the promise to directly or indirectly affect 
entire populations or species.  Disturbances in the environmental balance can bring about 
catastrophes or unanticipated deteriorations of entire ecosystems. 
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